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GENERAL INTRODUCTION 
An Explanation of the Dissertation Organization 
This thesis contains a compilation of four papers that will be 
submitted to scholarly journals. Therefor a general literature review follows 
in which the background and significance of the work are discussed. 
Following this introduction are each of the papers in their entirety. A 
general summary of all the papers follows, concluded with a literature cited 
section containing the references cited in the general introduction and 
general summary. 
Literature Review 
Reversible post-translational modification is one mechanism cells have 
developed in order to respond rapidly to various stimuli. One common post-
translation modification is the addition of a phosphate group from ATP to 
specific amino acids of cellular proteins. The best understood 
phosphorylation reactions in eukaryotic systems are those that occur on 
serine, threonine, and tyrosine residues. There are three distinct classes of 
enzymes involved in regulating the cellular phosphorylation of proteins: 
A) Those that act only on serine and threonine. 
B) Those that act only on tyrosine. 
C) Those that can act on serine, threonine, and tyrosine. 
The nomenclature that is evolving to characterize these enzymes is as 
follows. Proteins that are responsible for the addition of the phosphate 
group are termed kinases, and those responsible for removal of the 
phosphate from cellular proteins are termed phosphatases. The 
identification of enzymes in the three functional classes is achieved with an 
additional term; therefor, we have protein serine/threonine kinases and 
phosphatases, protein tyrosine kinases and phosphatases, and dual 
specificity (i.e., those enzymes capable of working on serine/threonine AND 
tyrosine residues) protein kinases and phosphatases. 
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Phosphorylation of serine and threonine residues was first discovered by 
Krebs and Fischer in 1955 while they were looking at epinephrine induced 
glycogen breakdown in skeletal muscle (Fischer & Krebs, 1955). 
Phosphorylation of tyrosine residues was first reported in 1980 by Hunter 
and Sefton, who were studying the transforming gene product of the avian 
sarcoma virus src (Hunter & Sefton, 1980). The initial description of dual 
specificity enzymes occurred in 1991, when a yeast protein kinase, YPKl 
(Dailey et al., 1990a) and later renamed MCKl (Dailey et ai., 1990b), and a 
phosphatase cloned from the vaccinia virus, VHl (Guan et al., 1991), were 
shown to phosphoiylate and dephosphorylate serine, threonine, and 
tyrosine residues. 
All the protein kinases so far discovered share homology to one another, 
indicating that these enzymes have evolved via divergent evolution (Hanks et 
al., 1988). In contrast to the protein kinases, the phosphatases so far 
discovered represent at least three distinct gene families, two of which 
encode protein ser/thr phosphatases and one which encodes both the 
protein tyrosine phosphatases and the dual specificity phosphatases (Pot & 
Dixon, 1992). One of the protein ser/thr phosphatase gene families consists 
of two isozymes of PP-2C. The second, termed the PP1/2A/2B gene family, 
consists of eleven members. Ten are eukaiyotic enzymes (PPl, PP2A, PP2B, 
Rdgc, SIT4, PP2BW. PP-V, PP-X, PP-Y and PP-z) and the eleventh, termed 
ORF 221, is found in prokaiyotes. Additionally, two or more isozymes have 
been identified for several members of this family. The protein tyrosine 
phosphatases and the dual specificity phosphatases also have many 
members (discussed below). 
Processes controlled by serine and threonine phosphorylation. Initially, 
serine/threonine phosphorylation was implicated in regulating the activity 
of various metabolic enzymes, including glycogen synthase, glycogen 
phosphorylase, and phosphoiylase kinase (Cohen, 1983). Serine/threonine 
phosphorylation has now also been implicated in such diverse roles as ion 
channel regulation (Klein & Kandel, 1980; Moss et al., 1992; Tilly et al., 
1992), p adrenergic receptor and rhodopsin desensitization (Wilden et al., 
1986), cell cycle progression (Riabowol, et al., 1989), mitogenesis (Thomas et 
al., 1992), smooth muscle contraction (Kamm & Stull, 1985), and 
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neurosecretion (Bahler & Greengard, 1987). 
Processes controlled by tyrosine phosphorylation. Although tyrosine 
phosphorylation constitutes only 0.01-0.05% of the total phosphate 
incorporated into proteins in normal cells (CoUett et al., 1980), it has been 
implicated in many key cellular processes. Some of these processes include: 
control of mitogenesis (Ullrich & Schlessinger, 1990) and oncogenesis 
(Bishop, 1991), T-cell and B-cell activation (Pingel & Thomas, 1989; and 
Justement et al. 1991, respectively), platelet activation (Golden & Brugge, 
1989; Dhar et al., 1990), long term potentiation (O'Dell et al., 1991), 
regulation of membrane potential (Hopfield et al., 1988; Wagner et al., 
1991), insulin effects (Ullrich & Schlessinger, 1990), and the transition 
between G2 and M-phase (Gould & Nurse, 1989). Recent evidence also 
points to a role for tyrosine phosphorylation in the pathogenesis of the 
human immunodeficiency virus (HIV) (Cohen et al., 1992). 
Protein tyrosine phosphatases. The protein tyrosine phosphatase (FTP) 
family is a large (over 60 identified members) group of enzymes that 
continues to be expanded at a very rapid rate. The PTP consensus domain, 
as defined by sequence homology amongst the various PTP clones thus far 
discovered, is 230 amino acids in length and contains an area called the HO 
box. The HO box is an 11 amino acid stretch of high homology with the 
consensus sequence [I/V]HCXAGXXR[S/T]G, where X stands for an 
unconsented amino acid (Pot & Dixon, 1992). Additionally, the cysteine 
residue in this HC box has been shown to be essential for PTP activity, and 
upon substrate dephosphorylation it forms a phospho-enzyme intermediate 
(Pot & Dixon, 1991). The PTP gene family (which, because of homology, 
includes the dual specificity phosphatases) can be subdivided into at least 
three classes: transmembrane linked, intracellular, and the dual specificity 
phosphatases. 
The transmembrane (TM) class of PTP's are single pass transmembrane 
proteins with one or two intracellular PTP domains and an extracellular 
domain of variable structure (Pot & Dixon, 1992; Krueger & Saito, 1992; 
Fischer et al., 1991). The transmembrane class of PTP's can be subdivided 
into five distinct groups based on the characteristics of the extracellular 
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domain (Fischer et al., 1991). One group, typified by CD45, are heavily 
glycosylated and bear the hallmarks of ligand binding domains. The second 
group of TM FTP'S, like LAR (Leukocyte common ^tigen Related protein) are 
characterized as having extracellular domains with similarity to both cell-
cell adhesion molecules (e.g. N-CAM and fibronectin type III) and Ig-like 
molecules. The third group of enzymes are those that have only fibronectin 
type III like repeats in their extracellular sequences like HPTP-p. The fourth 
group of enzymes consists of PTPÇ which contains an extended extracellular 
domain lacking cysteine residues and an amino terminal portion with 
homology to carbonic anhydrase. The final group are those that have only a 
small extracellular domain, with the prototype being HPTP-a. 
The transmembrane class of PTP's usually contain two PTP-like domains, 
with the exception of HPTP-p, which has only one PTP-like domain. The 
functional significance of the two PTP domains is unknown. Furthermore, 
early studies questioned whether the second domain of CD45 and LAR had 
phosphatase activity, since replacement of a critical cysteine with alanine in 
the first domain destroys PTP activity, while mutation of this cysteine in the 
second domain has no effect (Streuli et al., 1990; Pot & Dixon, 1991). 
However, the second domain of HPTP-a has been shown to have limited PTP 
activity (Wang & Fallen, 1991), and recent studies with CD45 have shown 
that, under certain conditions, the second domain of this PTP is active also 
(Tan et al., 1993). 
The intracellular class of phosphatases can also be subdivided into those 
that have additional sequences N-terminal to the catalytic domain and those 
that have additional sequences C-terminal to the catalytic domain. These 
additional sequences often contain motifs that may be involved in cellular 
localization. The Drosophila phosphatase, dPTFGlF, contains a 53 amino 
acid domain C-terminal extention that is responsible for its nuclear 
localization (McLaughlin & Dixon, 1993). PTP-1 has a C-terminal extension 
that allows it to associate with the endoplasmic reticulum (Frangioni et al., 
1992). FTP-MEG, a phosphatase cloned from megakaryocytes, contains a N-
terminal extension that shows homology to protein 4.1 in a region thought 
to mediate inositolphospholipid-dependent association with glycophorin 
(Minxiang et al., 1991). Additionally, several PTP's have been cloned that 
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contain tandem repeats of SH-2 domains (which have been shown to bind 
tyrosine phosphorylated proteins and peptides) N-terminal to the PTP-like 
domain. Some of these SH-2 containing PTP's include: PTP-IC (also known 
as SH-PTPl, HCP, and HSP), PTP-ID (also known as SH-PTP2 and syp PTP), 
and the protein product of the Drosophila corkscrew gene. 
The third class of PTP's are the dual specificity phosphatases, so named 
because of their unique ability among the members of the PTP family to 
dephosphoiylate serine and threonine residues in addition to tyrosine (Guan 
et al., 1991). The prototype for this class is the vaccinia virus phosphatase 
VH-1. Recently, several proteins with high homology to VH-1 have been 
isolated from various organisms. Expression of YVHl, isolated from the 
yeast S. cerevisiae (Guan et al., 1992), was found to be induced by nitrogen 
starvation, and expression of the mouse 3CH134 (Charles et al., 1992) and 
the human PAC-1 phosphatases were induced by mitogens. Yet another 
human VH-1 like phosphatase, CLIOO, was found to be induced by oxidative 
stress and heat shock (Keyse & Emslie, 1992). The VH-1 like class of PTP's 
also contains the yeast S. pombe cell division cycle gene product cdc25 (Pot 
et al., 1992), as well as the cdc25 homologs isolated from various other 
species. 
Tissue specific distribution qfPTFs. One possible explanation for the vast 
number of PTP's present in eukaryotes is that specific PTP's have evolved for 
specific functions. In support of this hypothesis, several PTP's have been 
shown to have tissue dependent expression patterns or are developmentally 
regulated. One example of this is CD45, which is found only in nucleated 
cells of hematopoeitic lineage. The Drosophila PTP DFTP99A is produced 
specifically in a subset of CNS neurons, some of which pioneer the CNS 
axon scaffold, in a developmentally regulated fashion (Yang et al., 1991). 
Another Drosophila PTP, DPTPIOD, is also expressed in a developmentally 
regulated fashion specifically in the extending axons of the embryonic CNS 
(Yang et al., 1991). Other PTP's that have been shown to have local areas of 
high expression include stepPTP, striatum enriched FTP (Lombroso et al., 
1991), and PTP-1, which is highly expressed in the rat brain hippo campus 
(Guan et al., 1990). 
Direct evidence for PTP Junctions. There is direct evidence for the 
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involvement of specific PTP's in immune function, cell cycle regulation, 
Drosophila pattern formation, and bacterial virulence. CD45, a lymphocyte 
specific transmembrane FTP, has been shown to be essential for T and B cell 
activation via their respective antigen receptors (Pingel & Thomas, 1989; 
Justement et al., 1991). The corkscrew gene encodes a FTP that is required 
for cell fate determination of the Drosophila embryo (Perkins et al., 1992). It 
is downstream from the receptor tyrosine kinase, torso, in a signal 
transduction pathway that also includes a serine/threonine protein kinase, 
D-raf, and two transcription factors, tailless and huckebein. Bacteria of the 
genus Yersinia have been shown to require active YOP-2B phosphatase for 
virulence (Guan & Dixon, 1990; Bliska et al., 1991). It has also been shown 
that YOP-2B immunoprecipitates from macrophages infected with Y, 
psuedotuberculosis expressing a catalytically inactive Y0P-2B contain two 
phosphotyrosine containing proteins, of MW 120- and 55-kD (Bliska et al., 
1992). Both proteins that immunoprecipitated with the inactive YOP-2B 
were shown to have tyrosine kinase activity, suggesting that the primary in 
vivo substrates for this FTP may be activated tyrosine kinases. 
Yeast represent simple model systems that are extremely ammenable to 
genetic, molecular biology, and biochemical approaches. Several protein 
tyrosine phosphatases have been cloned from yeast and a portion of their 
physiological functions identified. Genetic and biochemical evidence 
indicates that in the fission yeast, S. pombe, cdc25 dephosphorylates the 
cdc2 component of M-phase promoting factor (MPF) thus triggering MPF 
activation and the transition from G2 to M phase (Gautier et al., 1991). 
Three other protein tyrosine phosphatases have been cloned from S. pombe, 
and have been termed pyp-1, pyp-2, and pyp-3. pyp-3 has been shown to 
act cooperatively with cdc25 to dephosphoiylate the tyr-15 phosphorylation 
site of cdc2 (Millar et al., 1992a). The other two PTP's have been shown to 
be negative regulators of mitosis that act upstream of weel and mikl, the 
kinases responsible for the tyrosine phosphorylation of cdc2 (Millar et al., 
1992b; Ottilie et al., 1992). YVH-1, cloned from S. cerevisiae, has been 
shown by homologous recombination to decrease cell growth rate (Guan et 
al., 1992), PTP2, another gene cloned from S. cerevisiae, was isolated in a 
screen looking for genes involved in the N-end rule pathway, indicating that 
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this FTP may function in protein degradation (Ota & Varshavsky, 1992). 
Indirect evidence for FTP Junctions. Overexpression of recombinant PTP's 
or introduction of PTP's into cells by microinjection or cell permeabilization 
has provided evidence that PTP's are also involved in mitogenesis, oncogenic 
cell transformation, cell cycle regulation, insulin action and amylase 
secretion. Overexpression of a truncated form of human T-cell PTP in baby 
hamster kidney cells inhibited their growth rate by 50% (Cool et al., 1990). 
Overexpression of human placenta PTP IB (Brown-Shimer et al., 1992) or 
rat brain PTP-1 (Woodford-Thomas et al., 1992) inhibited transformation by 
the neu or v-src oncogenesis, respectively. Conversely overexpression of 
HPTPa, a tranmembrane PTP, was shown to induce oncogenic cell 
transformation in Rat 1 fibroblasts (Zheng et al., 1992). Overexpression of a 
truncated form of T-cell PTP lead to cytokinetic failure and asynchronous 
nuclear division in baby hamster kidney cells (Cool et al., 1992). 
Microinjection of a truncated form of human placental PTP IB, a 
cytoplasmic PTP, delayed insulin, progesterone or MPF induced maturation 
of Xenopus oocytes (Tonks et al., 1990). Microinjection of PTP-IB also 
inhibited insulin induced activation of S6 peptide kinase and ribosomal 86 
phosphorylation (Cicirelli, et al., 1990). Addition of rat brain PTP-1 to 
streptolysin O permeabilized pancreatic acinar cells stimulated Ca+2. 
induced amylase secretion (Jena et al., 1991). 
Other factors, such as specific expression in a tissue with a defined 
function, or stimulus dependent expression can give an indication of other 
roles of PTP's as well. For example, the high level of expression of rat brain 
PTP-1 in the hippocampus may indicate a role for this enzyme in long term 
potentiation. In support of this hypothesis, stimulation of hippocampal cells 
with glutamate was shown to induce the rapid tyrosine phosphorylation of 
several proteins, one of which was the serine/threonine kinase ERK-1 
(Bading & Greenburg, 1991). Recent experiments have also shown that a 
protein tyrosine kinase inhibitor, genestein, was able to inhibit the 
formation of long term potentiation in hippocampal cells (O'Dell et al., 1991). 
Additionally, it has been shown that in human skin fibroblasts, oxidative 
stress and heat shock are able to induce the expression of a VH-1 like PTP, 
ClOOPTP, by 20-fold (Keyse & Emslie, 1992). Interestingly, this PTP also 
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has 97% sequence identity to that of a recently described mouse cDNA, 
3CH134, that was found to be a growth factor-inducible immediate early 
gene (Charles et al., 1992). 
PTP's also may be involved in tumor suppression and growth inhibition. 
A strong correlation has been reported between chromosomal abberations in 
the PTPy loci and many renal carcinomas (LaForgia et al., 1991). 
Additionally, correlations have been found for chromosomal abberations in 
or near the loci of CD45, PTPIB, RPTPa, LAR, and the T-cell PTP 
(Charbonneau & Tonks, 1992). LAR is a transmembrane protein tyrosine 
phosphatase with a wide tissue distribution (Streuli et al., 1990), and N-
CAM like repeats in the extracellular domain. These repeats are similar to 
those of a putative colorectal tumor suppressor gene (DCC), and have lead 
some researchers to speculate that LAR may play a role in negative growth 
regulation by cell-cell interactions (Fearon et al., 1990). 
Physiological modifiers of PTP activity: Several physiological modifiers of 
PTP activity have been identified. Ingebritsen has purified two heat stable 
PTP inhibitors (Ingebritsen, 1988) from bovine brain and has characterized 
them against the seven cytosolic biochemical PTP activities previously 
identified in bovine brain (Jones et al., 1988). These inhibitors were shown 
to have some degree of selectivity (differences in ICso's of over 200-fold) 
amongst the PTP's tested. PTP-5 was inhibited to the greatest degree, with 
an estimated IC50 for inhibitor H of 0.4 nM. Another potential mechanism 
for modulating PTP activity in vivo is by phosphorylation. Trowbridge has 
found that CD45 is phosphoiylated on serine residues in resting T cells, and 
when [Ca+2]j is increased, the level of CD45 serine phosphorylation 
decreases (Ostergaard & Trowbridge, 1991). Concommitant with this 
decrease in phosphorylation is a decrease in membrane associated PTP 
activity. Another possible mechanism of regulating the activity of CD45 is 
by association with other proteins. Recent studies have shown that the 
cytoskeletal protein fodrin is associated with CD45 in vivo (Lokeshwar & 
Bourguignon, 1992). Additionally, it was shown in vitro thai, fodrin, and the 
closely related protein spectrin, can both bind CD45 and that this 
association causes an increase in the PTP activity of CD45. The SH2 
containing PTP's PTP-IC and PTP-ID have been shown to become 
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phosphoiylated on tyrosine in response to EGF and PDGF (Feng et al., 1993; 
Vogel et al., 1993). In addition, this phosphorylation was shown to increase 
the tyrosine phosphatase activity of PTP-ID (Vogel et al., 1993). These 
phosphatases may also be regulated by association of their SH2 domains 
with cellular phosphotyrosine residues. Indeed, both PTP-IC and FTP-ID 
have been found to associate with growth factor receptors only after 
stimulation (Feng et al., 1993; Vogel et al., 1993). Yet another mechanism 
of modulating PTP activity has been found in the somatostatin signal 
transduction cascade. Somatostatin is a growth inhibitory tetradecapeptide 
hormone that activates a pertusis toxin-sensative heterotrimeric G-protein. 
It has now been shown that treatment of an undifferentiated human 
pancreatic cancer cell line (MIA PaCa-2) with somatostatin causes an 
increase in membrane associated PTP activity and that this activation of PTP 
activity is pertusis toxin-sensitive (Pan et al., 1992). 
Regulators of in vitro PTP activity. Several compounds have been found to 
inhibit, inactivate or enhance the activity of PTP's in vitro. All PTP's have an 
absolute requirement for reducing conditions, owing to their active site 
cysteine residue. In agreement with this is the finding that the cysteine 
modifying reagents iodoacetate and iodoacetamide were both able to 
inactivate LAR (Pot et al., 1991). In addition, phenylarsine oxide, which 
covalently reacts with vicinal thiols was found to inactivate CD45 in vitro 
(Garcia-Morales et al., 1990). Another compound that has been found to be 
inhibitory for all PTP's tested thus far is the phosphate analog 
orthovanadate (V04"^). Further experiments in this lab have shown that 
vanadate irreversibly inactivates PTP-1. Zn+2 has also been found to inhibit 
most intracellular PTP's, but was stimulatory for the transmembrane PTP 
CD45 (Tonks & Charbonneau, 1989). In addition, polyanions such as 
heparin and polyA oligonucleotides, as well as polyacidic polypeptides, such 
as poly (Glu :iyr) inhibit all PTP's, but the ICso's for inhibition of the 
transmembrane PTP's were significantly higher (Tonks & Cheirbonneau, 
1989). There have also been several reports on the effects of polybasic 
compounds on the activities of transmembrane PTP's. For example, 
spermine and poly(lysine) have been shown to be activators of CD45 (Tonks 
et al., 1990) and HPTP-p (Itoh et al., 1992). These experiments have been 
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complicated, however, in that most of these effects have been shown to 
occur only with the full length (i.e. transmembrane and extracellular 
domains, as well as cytoplasmic domains) molecules, or the effects are 
observed only with certain substrates (Itoh et al., 1992). 
Project Introduction 
Despite the wide variety of processes now known to involve protein 
tyrosine phosphatases, little is known about their in vivo substrates or how 
they carry out recognition and dephosphorylation of these substrates. We 
have chosen to study these questions with intracellular PTP's from 
prokaiyotic and eukaiyotic sources, as well as PTP's of the transmembrane 
class. Three approaches have been used in this study. The first approach 
involved the identification of structural elements in the vicinity of the 
phosphorylated tyrosine that contribute to substrate recognition using 
model PTP substrates. The second approach involved defining the substrate 
specificity of these PTP's using peptides based on proteins with known in 
vivo sites of tyrosine phosphoiylation. The final approach that was taken 
involved the identification of active site PTP residues involved in substrate 
binding and/or catalysis. 
The PTP's that were used in these experiments are: 
PTP-1 is an intracellular PTP cloned from rat brain. The PTP-1 we have 
used is a truncated, recombinant form expressed as a fusion protein with 
glutathione-S-transferase. After purification by glutathione beads, the 
glutathione-S-transferase portion was removed from the phosphatase by 
cleavage with thrombin. The C-terminal 111 amino acids (which lie 
outside of the catalytic domain) were deleted by replacing the lys-323 
codon with a stop codon. 
PTP-5 constitutes the major cytosolic biochemical PTP activity isolated 
from bovine brain. PTP-5, a 46 kD intracellular PTP, appears to be 
distinct from rat brain PTP-1 because of differences in sensitivities to the 
inhibitors Zn2+ and the protein inhibitor H, as well as a lack of antibody 
cross-reactivity. 
YOP-51 is an intracellular phosphatase encoded on a plasmid isolated 
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from the bacteria Yersinia enterocolitica that is required for virulence of 
this microorganism. The enzyme that has been used here is a full-
length, recombinant protein that has been expressed and purified to 
homogeneity from E. colL 
CD45 (also referred to as LCA, Leukocyte (Common Antigen) is a 
transmembrane phosphatase found exclusively on cells of hematopoietic 
lineage that constitutes about 10% of the mass of T-cell membranes. The 
CD45 used in these experiments is a full length form 
chromatographically purified from Jurkat cell membranes. 
LAR (Leukocyte common Antigen Related protein) is another 
transmembrane phosphatase, but with a wide tissue distribution. The 
LAR that was used is a soluble, recombinant form of rat brain LAR tliat 
lacks the extracellular and transmembrane domains, but retains both 
FTP catalytic domains. The enzyme was expressed and purified to 
homogeneity from E. colt 
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PAPER 1. ACIDIC RESIDUES ARE INVOLVED IN SUBSTRATE 
RECOGNITION BY TWO SOLUBLE PROTEIN TYROSINE 
PHOSPHATASES, PTP-5 AND rrbPTP-l 
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Acidic Residues Are Involved in Substrate Recognition by Two Soluble 
Protein Tyrosine Phosphatases, PTP-5 and rrbPTP-lt 
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FOOTNOTES 
1 Abbreviations: FTP, protein tyrosine phosphatase: rrbPTP-1, a 
recombinant form of rat brain PTP-1: RCM-lysozyme, reduced, 
carboxyamidomethylated and maleylated-lysozyme: EGF, epidermal growth 
factor: TFA, trifluoroacetic acid; pNPP, p-nitrophenyl phosphate: TCA, 
trichloroacetic acid; HPLC, high performance liquid chromatography; FPLC, 
fast protein liquid chromatography: PMSF, phenylmethylsulfonyl fluoride: 
TPCK, tosylphenylchloromethyl ketone. 
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ABSTRACT 
The mechanisms for substrate recognition by two cytoplasmic protein 
tyrosine phosphatases, PTP-5 and rrbPTP-1, were investigated. 
Phosphorylation sites on tyrosine phosphorylated casein, a model PTP 
substrate, were characterized. Two peptides based on casein 
phosphorylation sites and one peptide based on the tyrosine 
phosphorylation site of reduced, carboxyamidomethylated and maleylated-
(RCM) lysozyme were tested as PTP substrates. The three peptides were 
dephosphorylated by PTP-5 and rrbPTP-1 at rates comparable to those of 
the corresponding sites on the intact proteins. This indicates that peptides 
based on the two model PTP substrates, casein and RCM-lysozyme, 
contained all or most of the structural information necessary for PTP-5 and 
rrbPTP-1 substrate recognition. 
Structural elements required for substrate recognition by PTP-5 and 
rrbPTP-1 were also investigated. Km values for dephosphoiylation of three 
simple aromatic phosphate esters (phosphotyrosine, p-nitrophenyl 
phosphate, and phenyl phosphate) by rrbPTP-1 were about 5,000 fold higher 
than those obtained for the peptide and protein substrates. This indicates 
that recognition of protein and peptide substrates involves structural 
elements in addition to the phosphate group and aromatic tyrosine ring of 
phosphotyrosine. Analysis of the effects of truncations and alanine for polar 
substitutions on the reactivity with PTP-5 and rrbPTP-1 of peptides based on 
casein, RCM-lysozyme and angiotensin II indicated that asp or glu within 
the first five residues on the N-terminal side of phosphotyrosine increased 
peptide reactivity with both PTP's. Asn residues were unable or only weakly 
able to substitute for asp residues. These results indicate that one or more 
acidic residues on the N-terminal side of phosphotyrosine enhance peptide 
reactivity with PTP-5 and rrbPTP-1 in an additive fashion. 
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INTRODUCTION 
Protein tyrosine phosphatases (PTP'sl) are enzymes that remove 
phosphate from tyrosine residues of cellular proteins. They belong to a 
rather large gene family found in eukaryotes from yeast to man, in 
prokaryotes of the genus Yersinia and vaccinia virus (Pot & Dixon, 1992; 
Krueger & Saito, 1992; Fischer, et al., 1991). PTP's can be grouped into 
three classes. The transmembrane class are single pass transmembrane 
proteins with one or two intracellular PTP domains and an extracellular 
domain of variable structure (Pot & Dixon, 1992; Krueger & Saito, 1992; 
Fischer, et al., 1991). The cytoplasmic class lacks the transmembrane and 
extracellular domains and has only a single PTP domain (Pot & Dixon, 1992; 
Fischer, et al., 1991). The dual-specificity class has the unique property 
that its members remove phosphate from ser and/or thr residues as well as 
tyr (Gautier, et al., 1991; Pot & Dixon, 1992). 
A critical question in understanding PTP function is how do they 
recognize their substrates? In this paper we have studied the molecular 
basis for substrate recognition by two cytoplasmic PTP's. PTP-5 is the major 
soluble PTP activity towards phospholyrosyl-casein in bovine brain (Jones, 
et al., 1989). PTP-1 is an endoplasmic reticulum localized rat brain PTP that 
is closely related to human placenta PTP IB (Guan, K., et al., 1990). 
Although the primary sequence of PTP-5 is not known, it can be 
distinguished from PTP 1 immunologically and based on sensitivity to 
inhibition by Zn^+ (Kordiyak, G. & Ingebritsen, T. S., unpublished results). 
Rat brair.iPTP-1, human placenta PTP IB and bovine brain PTP-5 are among 
the best biochemically characterized PTP's. Previous studies have shown 
that PTP-5 has an very low Km for casein (130 nM) (Jones, et al., 1989) and 
that a truncated form of human placenta PTP IB has a very low Km for 
reduced, carboxyamidomethylated and maleylated (RCM)-lysozyme (80 nM) 
(Tonks, et al., 1988). However there has not been any attempt to identify 
features of substrate structure which might account for this high reactivity 
with casein and RCM-lysozyme. We now show that tryptic phosphopeptides 
derived from casein and RCM-lysozyme mimic the reactivity of the 
corresponding tyrosine phosphorylation sites on the intact proteins and that 
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acidic residues on the N-terminal side of phosphotyrosine promote substrate 
reactivity with bovine brain PTP-5 and rrbPTP-1, a truncated, recombinant 
form of rat brain PTP-1, 
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MATERIALS AND METHODS 
Materials. The C8 (Brownlee Aquapore RP-300, 0.46 x 22 cm) reverse-
phase HPLC column was from Rainin. The mono Q (HR 5/5) FPLC column 
was from Pharmacia. [Y-32p]ATP was purchased from ICN or prepared from 
32p-inorganic phosphate (ICN) as in (Johnson & Walseth, 1979). 
Trifluoroacetic acid (TFA) and HPLC grade acetonitrile were from Applied 
Biosystems, Inc.. Bovine casein (a mixture of 70% «si ®s2 ^nd 30% P + K 
caseins), TPCK-treated trypsin from bovine pancreas, calf intestinal alkaline 
phosphatase attached to beaded agarose, angiotensin II derivatives, p-
nitrophenyl phosphate (pNPP), phenyl phosphate, and free phosphotyrosine 
were from Sigma. Alpha-chymotiypsin was from Worthington Biomedical 
Corporation. RCM-lysozyme was prepared by maleylation, reduction of 
disulfide bonds and reaction of free sulfhydiyl groups with iodoacetamide to 
expose tyrosine residues as in (Tonks, et al., 1991). Sources of other 
reagents have been previously described (Jones, et al., 1989). 
Peptide synthesis. Lysozyme- and casein-related peptides were 
synthesized in the Iowa State University Protein Facility by solid phase 
methodology on an Applied Biosystems 430A peptide synthesizer using N-
methylpyrrolidone or dimethyl formamide as solvent for the coupling 
reactions and t-butyloxycarbonyl protecting groups. Peptides were cleaved 
from the resin and side chains deprotected by treatment with anhydrous 
HF. The peptides obtained in this way were 70-90% pure. Peptides were 
characterized by amino acid analysis to verify amino acid composition and 
fast atom bombardment-mass spectrometry to verify molecular weight after 
purification by reverse phase HPLC (CI8 column) using a acetonitrile/ 0.1% 
(v/v) TFA gradient {1%/min) at a flow rate of 1 ml/min. 
Preparation of 32P-labeled substrates. Casein and RCM-lysozyme were 
phosphoiylated by the insulin receptor using reaction conditions previously 
described for the phosphorylation of casein (Jones, et al., 1989; Ingebritsen, 
1991). Phosphate incorporation was 1-5 nmol/mg for casein and 4-12 
nmol/mg for RCM-lysozyme. When casein and RCM-lysozyme were used as 
substrates they were further processed to remove unreacted ATP as 
previously described (Jones, et al., 1989; Ingebritsen, 1991). 
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Synthetic lysozyme-, casein- and angiotensin Il-related peptides were 
phosphorylated by the intact heterotetrameric insulin receptor kinase 
under the same reaction conditions used for casein and RCM-lysozyme, or 
by a soluble form of the P subunit (BIRK) using slightly modified conditions 
in which insulin and the detergent triton X-100 were omitted from the 
reaction buffer. Stoichiometrics of phosphorylation ranged from 0.02-0.85 
mol/mol for the various peptides. Lysozyme- and casein-related peptide 
phosphorylation reactions were stopped with an equal volume of 0.1% (v/v) 
TFA and purified either by a combination of chromatography on Sep-Pak C-
18 cartriges to remove unreacted ATP, followed by reverse phase 
chromatography (C-8 column), or by reverse phase chromatography (C-8 
column) alone. Sep-Pak cartridges were washed with 10% (v/v) 
acetonitrile/0.1% (v/v) TFA to remove unreacted ATP and phosphopeptides 
were eluted with 100% (v/v) acetonitrile/0.1% (v/v) TFA. Phosphopeptides 
were separated from the non-reacted peptides by reverse phase HPLC (C8 
column). Baseline separations of phosphorylated and unphosphorylated 
peptides were achieved using a linear acetonitrile/0.1% (v/v) TFA gradient 
(0.2%/minute) across the two peptide peaks. Angiotensin Il-related peptide 
phosphorylation reactions were terminated and processed in the same way 
but it was not possible to completely separate phosphorylated angiotensin 
Il-related peptides from unreacted peptides by HPLC chromatography (C8 
column). 
Two phosphopeptides 69-3 and 69-4 were generated by chymotrypsin 
digestion (1:12,5 w/w) of HPLC pure phosphopeptides 67-2 and 66-1, 
respectively (see Table 3 for sequences). The HPLC pure phosphopeptides 
were dried using a Speed-Vac, dissolved in 100 ^il of 1% (w/v) ammonium 
bicarbonate, and digested for 3.5 hours at 30°. The digestion was stopped 
with 400 (j,l of 0.1% (v/v) TFA and the products separated by reverse phase 
HPLC (C8 column) using a linear acetonitrile/ 0.1% (v/v) TFA gradient (1% 
/minute) at a flow rate of 1 ml/min. In each case a single 32p_iabeled 
digestion product was observed. In order to identify the digestion products, 
the phosphopeptides were dephosphorylated by incubation with 2 units of 
rrbPTP-1 for 12 hours and subjected to amino acid analysis. The results 
showed that the digestion products arose due to cleavage by chymotrypsin 
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after the leucine residue rather than after the phosphorylated tyrosine 
residue. 
Peptide Mapping. For casein the phosphorylation reaction was stopped 
by addtion of trichloroacetic acid (TCA) to a final concentration of 20%, the 
precipitate was washed with 5% TCA and redissolved in 50 mM ammonium 
bicarbonate, pH 8.5-1.0 mM EDTA-2 M urea (buffer A). TPCK-trypsin (1:40 
w/w) was added and the mixture incubated at 30° for 16 hrs. An aliquot of 
the mixture was adjusted to pH 4 with TEA and subjected to reverse phase 
HPLC (Cg column). The column was developed with a linear acetonitrile-
0.1% TFA gradient (1%/min) at a flow rate of 1 ml/min. When peptide 
mapping reactions were run on an analytical scale, additional unlabeled 
casein was added to the tiypsin digestion reaction as a carrier. 
Peptide Sequencing. A tiyptic digest of phosphorylated casein was 
applied to an FPLC Mono Q column (Pharmacia) equilibrated with 20 mM 
Tris/HCl (pH 7.5 at 25°) and ^^P-peptides were eluted with a linear 0-1.0 M 
NaCl gradient (30 ml total volume) at a flow rate of 1 ml/min. Two 
radioactive peptide peaks were obtained eluUng at 300 mM NaCl (a mixture 
of peptides 1, 3 and 4) and 575 mM NaCl (peptide 2)(not shown). Casein 
peptides 1 and 2 were further purified to homogeneity by subjecting the 
leading edge of FPLC peak 1 and the entire FPLC peak 2 to reverse phase 
HPLC (C8 column, see before). The three peptides were sequenced by 
stepwise automated Edman degradation after an initial double coupling 
protocol using an Applied Biosystems model 470A gas-phase sequenator 
equipped with an on-line model 120A PTH-amino acid analyzer. Casein 
peptide 2 was also sequenced after dephosphorylation by overnight 
incubation with 0.5 units of immobilized calf intestinal alkaline 
phosphatase. 
PTP Assays. PTP assays using protein substrates were carried out using 
conditions previously described for the assays of PTP-5 (Jones, et al., 1989; 
Ingebritsen, 1991). The same procedure was used for peptide substrates 
except that 32p^ produced during the incubation was separated from 
unreacted phosphopeptide by either extraction of phosphomolybdate 
complexes into organic solvent (Shenolikar & Ingebritsen, 1984) or by 
binding unreacted phosphopeptide to activated charcoal (Streuli, et. al.. 
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1990). When pNPP was used as substrate the reaction was terminated by 
addition of 1 ml of 0.2 NaOH and the appearance of the p-nitrophenolate 
anion was monitored by absorbance at 410 nm (Jones, et al., 1989; 
Ingebritsen, 1991). Dephosphorylation of phosphorylated tyrosine and 
phenyl phosphate was monitored by the appearance of unlabeled inorganic 
phosphate using a malachite green assay (Van Veldhoven & Mannerts, 
1987). 
Apparent Km and Vm values for the two protein tyrosine phosphatases 
with the various substrates were determined from initial rate experiments 
using the non-linear regression analysis (Cleland, 1967). Kcat values for 
rrbPTP-1 were calculated based on a molecular weight of 37 kDa (see below). 
Expression and Purification of rrbPTP-l Jrom E. colt The PTP-1 used in 
this S;tudy is a truncated, recombinant form of rat brain PTP-1 (rrbPTP-1) 
produced by replacing the lys-323 codon with a stop codon by site-directed 
mutagenesis (Guan & Dixon, 1991). Two different vectors (pT7-PTPU323, 
and pKG-PTPU323) were used to express the phosphatase in E, coli and 
different protocols were used to purify each to homogeneity. rrbPTP-1 
expressed from pT7-PTPU323 or pKG-PTPU323 differ in their N-termini 
because of sequences added from their respective vectors. The authentic N-
terminus of rat brain PTP-1 is MEMEKE; the N-terminus from pT7-PTPU323 
is MARIRAQ, and that for pKG-PTPU323 is GSPGISGGGGGIRAQ. The two 
forms of rrbPTP-1 had comparable Km and kcat values with RCM-lysozyme, 
peptides 65-1 and 67-2, and p-nitrophenyl phosphate. 
The vector pT7-PTPU323 was used to express rrbPTP-1 in E. coli behind 
the bacteriophage T7 promoter (Guan, et al., 1990). E. coK from 1 liter of 
culture were lysed by French press in 10 mM Tris/HCl, pH 7.4, 1 mM 
EDTA", 0.2 mM PMSF, 0.05% 2-mercaptoethanol. The lysate was centrifuged 
at 12,000 X g for 15 min and the supernatant (extract) was further 
centrifuged at 100,000 x g for 60 min. The supernatant (cytosol) was 
applied to a DE-52 column (1.6 x 12 cm) equilibrated in 20 mM Tris/HCl 
(pH 7.0 at 25°)-0.1 mM EDTA-0.1 mM PMSF-0.1 mM benzamidine-0.2% 2-
mercaptoethanol (buffer A) at a flow rate of 30 ml/hr. The column was 
washed with buffer A until the protein concentration was < 0.02 mg/ml (~60 
ml). The DE-52 column was eluted with a 300 ml linear gradient (0-500 mM 
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NaCl) in buffer A at a flow rate of 30 ml/hr. 5 ml fractions were collected, 
the single peak of FTP activity, eluting between 80 and 120 mM NaCl, was 
pooled, dialyzed overnight against 1 change of 10 mM Imidazole/HCl, pH 
7.2-5 mM EDTA-0.5 mM benzamidine-0.5 mM PMSF-0.1% 2-
mercaptoethanol (buffer B) and applied to a thiophosphorylated RCM-
lysozyme column (1.5 x 15 cm) equilibrated with buffer B at a flow rate of 40 
ml/hr. The flowthrough material was collected and reapplied to the column. 
The column was washed with 4 bed volumes of buffer E and eluted with 
buffer B containing 250 mM NaCl. Fractions containing the FTP activity 
peak were pooled, dialyzed overnight against buffer B containing 50% 
glycerol and stored at -20°. 
Expression and purification of rrbPTP-1 from the vector pKG-PTPU323 
was accomplished essentially as in (Guan & Dixon, 1991). Briefly, rrbPTP-1 
was expressed in E. coli as a fusion protein with glutathione-S-transferase. 
The fusion protein was affinity purified directly from bacterial homogenates 
using glutathione-agarose, and the rrbPTP-1 liberated from the beads by 
cleavage of the fusion protein with the specific protease thrombin. 
Other Protein Preparations. The insulin receptor kinase was partially 
purified through the wheat germ agglutinin-Sepharose chromatography step 
as in (Treadwell, et al., 1989). BIRK, a soluble, catalytically active form of 
the P subunit of the insulin receptor tyrosine kinase, was purified from Sf9 
cells infected with recombinant virus through the Sepharose fast Q step as 
in (Herrera, et al., 1988). Bovine brain PTP-5 was partially purified through 
the phosphocellulose step as in (Jones, et al., 1989) and is free of other 
bovine brain PTP's. 
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RESULTS AND DISCUSSION 
Dephospkorylation by PTP-5 of individual tyrosine phosphorylation sites on 
casein and tryptic peptides derived from casein. Because of the high 
reactivity of phosphotyrosyl casein with PTP-5 it was of interest to identify 
the tyrosine phosphorylation sites on the protein. Tryptic digestion followed 
by peptide mapping revealed the presence of one major and three minor 
32p-peptides (Fig. 1). The major peptide (casein peptide 2) and a minor 
peptide (casein peptide 1) were sequenced (see below) and each contains a 
single tyrosine phosphorylation site. 
Because of the presence of multiple tyrosine phosphorylation sites on 
casein it was of interest to compare the rates of dephosphorylation of 
individual sites by PTP-5. The relative rates of dephosphorylation of the 
sites corresponding to casein peptides 1 and 2 by PTP-5 were determined. 
Tyrosine phosphorylated casein was incubated with PTP-5 and at various 
times aliquots were removed, digested with trypsin, and subjected to peptide 
mapping by reverse phase HPLC. The amount of phosphate remaining in 
the casein peptide 1 site and casein peptide 2 site was determined at each 
time point (Fig. 2A). The results show that phosphate was rapidly removed 
from the casein peptide 2 site whereas the casein peptide 1 site was hardly 
dephosphorylated at all. 
The rates of dephosphorylation of isolated casein peptides 1 and 2 by 
PTP-5 were also tested. It was found that casein peptide 2 was 
dephosphorylated by PTP-5 at a rate that was similar to that of intact 
casein, while casein peptide 1 was not dephosphorylated at an appreciable 
rate (Fig. 2B). Thus the rate of dephosphorylation of the isolated casein 
peptide 2 closely matched the rate of dephosphorylation of the casein 
peptide 2 site in the intact protein. Just as striking was the observation 
that the phosphate on the casein peptide 1 site was not removed at an 
appreciable rate in either the protein or the isolated peptide. 
Sequencing of casein peptide 1 and casein peptide 2. Casein peptide 2 
and casein peptide 1 were purified and sequenced by automated Edman 
degradation (Table 1). The sequences obtained for casein peptides 1 and 2 
corresponded to residues 200-205 and 46-55 of (Xs2"Casein, respectively 
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Figure 1. Peptide mapping of the tyrosine phosphorylation sites of casein. 
Reverse-phase HPLC chromatograms of total tiyptic digests are 
shown. Other conditions are described in Materials and 
Methods. 
Figure 2. Comparison of the rates of dephosphoiylation of the tryptic 
peptides containing the tyr-52 and tyr-203 phosphorylation 
sites of as2-ca8ein with the rates of dephosphoiylation of the 
corresponding sites on the intact protein. A. 
Dephosphoiylation of the casein peptide 2 site (closed circles) 
and the casein peptide 1 site (open circles) phosphorylation 
sites of intact ^^P-casein (50 nM) by PTP-5. Dephosphorylation 
reactions were stopped at the indicated times by addition of TCA 
(final concentration 25%), subjected to tryptic digestion and 
reverse phase HPLC (C8 column). 32p_ra.dioactivity associated 
with the tyr-52 site (casein peptide 2) and tyr-203 site (casein 
peptide 1) was quantitated by Cerenkov counting. B. 
Dephosphorylation of isolated casein peptide 2 (110 nM) (closed 
circles), casein peptide 1 ( 30 nM) (open circles) and intact 
. casein (100 nM) (closed triangles) by PTP-5. 32p.Qasein 
peptides 1 and 2 were released from intact casein by tryptic 
digestion and partially purified by reverse phase HPLC (08 
column). The two peptides as well as intact casein were 
incubated with PTP-5 for the indicated times and processed to 
determine the extent of ^^Pi released during the reaction. 
Further details are provided in Materials and Methods. 
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Table 1. Sequencing of Casein Peptides 1 and 2^ 
Casein Peptide 2 Casein Peptide 1 
Amino pmol/cycle Amino 
pmol/ 
cycle 
Cycle Acid -AP +AP Acid -AP 
1 N 396 - V 373 
2 A 447 976 I 379 
3 N 267 760 P 334 
4 E 277 816 Y 0 
5 E 368 496 V 331 
6 E 365 736 R 18 
7 Y 0 496 
8 S 249 268 
9 1 111 304 
10 G 40 165 
11 S 130 
12 S 122 
13 S 119 
14 E 150 
15 E 184 
16 S 65 
17 A 61 
18 E 113 
19 V 71 
20 A 50 
21 T 14 
22 E 78 
23 E 77 
24 V 40 
25 K 15 
a: Peptides were sequenced by automated Edman degradation before and 
after treatment with alkaline phosphatase (AP). Details of peptide 
isolation and sequencing are given in Materials and Methods. The 
inability to detect asn in cycle 1 after treatment of casein peptide 2 with 
alkaline phosphatase was due to a contaminant that obscured the asn 
peak. Quantities sequenced: casein peptide 2 (-AP), 0.65 nmol; casein 
peptide 2 (+AP), 2.0 nmol; casein peptide 1 (-AP), 0.35 nmol. 
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(Brignon, et al., 1977). Since, the bovine casein used in our experiments is 
a mixture of 70% («GI + AS2) arid 30% (P + K) caseins, this indicates that the 
®s2"Casein variant is the major substrate for the insulin receptor kinase. 
A gap in the sequence of each peptide was detected at the position 
expected for phosphotyrosine (Table 1). Additionally the sequence of casein 
peptide 2 was incomplete relative to that expected for a tryptic peptide 
probably due to the presence of phosphate on ser residues 56, 57, 58 and 
61 (Brignon, et al., 1977). The gaps in sequence at the positions of 
phosphotyrosine and phosphoserine were expected because of difficulties in 
detecting the phenylthiohydantoin derivatives of the phosphoamino acids 
(Patschinsky, et al., 1982; Turck, et al., 1991). In order to confirm the 
presence of phosphotyrosine and to obtain the complete sequence of casein 
peptide 2, it was treated with alkaline phosphatase to remove phosphate 
residues and then resequenced (Table 1). Following this treatment tyrosine 
was detected at cycle 7. Since each peptide contained only a single tyrosine 
residue, the phosphorylation sites of casein peptide 2 and casein peptide 1 
can be unambiguously assigned as tyr-52 and tyr-203, respectively, of ag2-
casein (Fig. 2C). 
Kinetic analysis of the dephosphorylation of casein peptide 2 and 
lysozyme peptide 65-1 by PTP-5. The ability of PTP-5 to dephosphorylate 
peptide substrates was futher analyzed by comparing the kinetic constants 
for dephosphorylation of casein peptide 2 with those for dephosphorylation 
of intact casein (Table 2). The Km and rel Vm for dephosphorylation of 
casein peptide 2 and intact casein were similar confirming the initial rate 
results shown in Figure 2B. Kinetic constants for dephosphorylation of 
casein peptide 1 were not determined since casein peptide 1 was not 
detectably dephosphorylated by PTP-5 (see before). 
RCM-lysozyme is another high affinity substrate for PTP-5 (Table 2) and 
the major site phosphorylated by a mixture of the epidermal growth factor 
and insulin receptor kinases is tyr-53 (Tonks, et al., 1991) . We have 
confirmed this for RCM-lysozyme phosphorylated by the insulin receptor 
kinase alone (results not shown). We synthesized a 16 residue peptide 
(lysozyme peptide 65-1) containing this phosphorylation site and tested it as 
a PTP-5 substrate in comparison with intact RCM-lysozyme (Table 2). The 
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Table 2. Kinetic Constants for Dephosphorylation of Tyrosine 
Phosphorylated Proteins and Peptides as well as Simple 
Aromatic Phosphate Esters by rrbPTP-1 and PTP-5^ 
rrbPTP-1 PTP-5 
Substrate Km 
Rel 
Vm Km 
Rel 
Vm 
\iM % |iM % 
Casein 0.08 100 0.15 100 
Casein Peptide 2 0.08 67 0.09 106 
Casein Peptide 121 0.20 116 0.64 57 
RCM-lysozyme 0.17 119 0.06 14 
Lysozyme Peptide 65-1 0.87 116 2.0 36 
Phosphotyrosine 5900 29 ND ND 
p-Nitrophenylphosphate 3500 32 ND ND 
Phenylphosphate 2010 65 ND ND 
a: For each PTP, Vm values are expressed relative to those obtained using 
casein as substrate. Relative values are presented because a partially 
purified PTP-5 preparation was used in these experiments. It should be 
noted that the Vm (10 |im"ol.min"l.min"l) previously obtained for 
dephosphorylation of phosphotyrosyl-casein by a nearly pure PTP-5 
preparation (Jones, et al., 1989) is similar to the Vm obtained with 
rrbPl A-l using this substrate (15 |imol.min"l.min"l). Data for rrbPTP-1 
with casein, p-nitrophenylphosphate and phosphotyrosine, and for PTP-5 
with lysozyme peptide 65-1 represent the mean of two kinetic 
experiments. The ranges of the Km and Vm values were with the 
variability seen in the experiments shown in Table 4. The other values 
are from a single experiment. Casein peptide 2 was isolated from 32p. 
phosphotyrosyl casein by tiyptic digestion and purified by reverse phase 
HPLC as described in Materials and Methods. Lysozyme peptide 65-1 
and casein peptide 121 were synthesized as described in Materials and 
Methods. 
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peptide was an excellent substrate with a Km of 2.0 |iM although this value 
was 40 fold greater than that obtained using intact RCM-lysozyme. The 
relative Vm value for the peptide was 2.5 fold higher than that for intact 
RCM-lysozyme. These results Indicate that casein peptide 2 and lysozyme 
peptide 65-1 retain most of their activity as PTP-5 substrates compared to 
the intact proteins from which they were derived. 
DephosphoryUxtion of casein and lysozyme peptides by rrbPTP-L In order 
to determine whether high reactivity with casein and lysozyme peptides was 
a unique feature of PTP-5, a truncated, recombinant form of rat brain PTP-1 
(rrbPTP-1) was assayed using casein, casein peptide 2, RCM-lysozyme and 
lysozyme peptide as substrates. Kinetic constants for dephosphorylation of 
the four substrates are shown in Table 2. The Kms for dephosphorylation of 
intact casein and casein peptide 2 were comparable whereas the Km for 
dephosphorylation of the lysozyme peptide was 6 fold higher than for Intact 
RCM-lysozyme. The Vm values for all four substrates were similar. Casein 
peptide 1, tested at a single substrate concentration of 100 nM, was 
dephosphorylated at a very slow rate (4 x 10® fold lower than the rate 
toward casein)(results not shown). These results are similar to those 
obtained for PTP-5 (see before). 
Reactivity of rrbPTP-1 with aromatic phosphate esters. In order to 
examine the importance of the phosphate group and of the aromatic 
tyrosine ring in FTP substrate recognition the reactivities of rrbPTP-1 with 
phosphotyrosine, p-nitrophenyl phosphate and phenyl phosphate were 
tested (Table 2). The Km values for the three substrates (2-5 mM) were 4-5 
orders of magnitude higher than the Km values obtained with casein and 
RCM-lysozyme. In contrast the Vm values for the three substrates were 
within a factor of three of those obtained with the two protein substrates. 
This indicates that recognition of protein and peptide substrates involves 
structural elements in addition to the phosphate group and aromatic 
tyrosine ring of phosphotyrosine. 
Effect of N- and C-terminal truncations on the reactivity of the lysozyme 
peptide with rrbPTP-1 and PTP-5. To further examine the importance of 
peptide structure in substrate recognition by rrbPTP-1, a series of lysozyme-
related peptides were synthesized. Lysozyme was chosen as the model 
31 
rather than casein because of technical complications with casein peptide 2 
synthesis. Casein peptide 2 contained several phosphoserine residues and 
was 9 amino acids longer than the lysozyme peptide. Each lysozyme-related 
peptide was phosphoiylated on tyrosine by the Insulin receptor kinase and 
the kinetic parameters for dephosphorylation by rrbPTP-l were examined 
(Table 3). 
Deletion of 3 or 5 residues from the C-terminus of the lysozyme peptide 
(peptides 67-2 and 69-3, respectively) slightly Improved reactivity by 
decreasing the Km for rrbPTP-1. In contrast deletion of 3 or 6 amino acids 
from the N-terminus of the lysozyme peptide (peptides 66-2 and 66-1, 
respectively) Impaired reactivity by increasing the Km for rrbPTP-1 by 6 and 
24 fold, respectively. The N- or C-termlnal deletions did not have any 
consistent effect on the Vm for the reactions. 
The effects of truncations (Table 3) and ala for polar substitutions CTable 
6) on the reactivity of lysosyme-related peptides with PTP-5 were examined. 
Deletion of 3 or 6 residues from the N-terminus of the lysozyme peptide 
Increased the Km for the reaction with PTP-5 by 4.2 and 31 fold, 
respectively. Conversely deletion of 3 or 5 residues from the C-terminus of 
the peptide did not increase the Km for the reaction with PTP-5. No 
consistent effects of deletions on the Vm's for the reaction with PTP-5 were 
observed. 
These results Indicate that peptide sequence on the N-termlnal side of 
phosphotyrosine influences peptide reactivity with both rrbPTP-1 and PTP-5 
by changing the Km for the reaction and that three amino acids on the C-
termlnal side of phoshotyroslne are sufllclent to maintain the low Km with 
the two FTP'S. 
Effect of acidic residues on lysozyme peptide reactivity with rrbPTP-1. 
Acidic residues have been implicated as determinants in substrate 
recognition by protein tyrosine kinases (see below). The effect of the asp 
residues at the -1 and -5 positions of the lysozyme peptide sequence was 
examined by comparing the reactivity of the wild-type lysozyme peptide (67-
2) with that of a peptide 115 which contains ala residues at both positions 
(Table 4). The presence of the two asp residues decreased the Km by almost 
an order of magnitude from 7.5 |iM to 0.8 pM without changing the Vm for 
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Table 3. Effect of Truncations on the Reactivity of Lysozyme-Related 
Peptides with rrbPTP-1 and PTP-5^ 
Peptide Sequence 
rrbPTP-1 PTP-5 
Km Vm Km Vm 
|iM % m % 
65-1 NTD6STDX0ILQINSR 0.87 100 2.0 100 
66-2 QSTDXOILQINSR 5.6 210 8.4 106 
66-1 DX6ILQINSR 21.2 82 62.5 75 
67-2 NTDQSTDXOXLQI 0.80 74 1.6 86 
67-1 GSTDX6ILQI 2.4 70 NDb ND 
69-3 NTDGSTDX6IL 0.52 37 1.7 82 
69-4 DÏGIL 21.8 92 ND ND 
a: For each PTP, Vm values are expressed relative to lyso^nne peptide 65-1. 
For rrbPTP-1, the Km and Vm data represent the means of 2-3 
determinations except for peptides 69-3 and 69-4 which represent data 
from a single kinetic analysis. The Km and Vm data for PTP-5 are from a 
single experiment. Peptide synthesis, peptide phosphorylation and 
phosphatase assay conditions are described in Materials and Methods, 
b: ND, Not determined. 
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Table 4. Effect of Ala for Polar Substitutions on Peptide Reactivity with 
rrbPTP-ia 
Peptide Sequence Km Rel Vm 
tiM % 
67-2 NTDGSTDYGILQI 0.8 ±0.1 100 
77 AAAGSTDYGILQI 2.8 ± 0.2C 100 ± 10 
112 NTDGSTDYGILQI 1.3 ±0.5 104 ± 10 
68-1 NTDGSTDYGILQI 0.9 ±0.1 113± 9 
111 NTDGSTDYGILQI 1.4 ± 0.3d 94± 10 
76 NTDGAAAYGILOI 2.6 ± 0.2c 110 ± 12 
68-2 NTDGSTDYGILQI 1.1 ±0.3 115± 11 
109 NTDGS&DYGILQI 0.7 ±0.2 96± 13 
110 NTDGSTAYGILQI 2.1 ± 0.3b 98 ± 5 
114 NTÎJGSTNYGILQI 4.8 ± 0.4c.e 121 ± 11 
115 NTAGSTAYGILQI 7.5 ± 0.7c.f 108 ±11 
^Km and Vm values represent the means ± SEM of 3 determinations made 
with separate phosphopeptide preparations. For each preparation Vm 
values were normalized to the Vm for peptide 67-2. Statistical 
comparisons were made using the Student-t test. Other conditions are 
described in Materials and Methods. 
bp<0.05 vs. control: Cp<o.01 vs. control: dp<.05 vs. peptide 77; 6p<0.05 vs. 
peptide 115: %)<0.01 vs. peptide 110. 
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the reaction. In contrast substitution of asn residues at positions -1 and -5 
for ala residues had only a small (less than two fold) effect on peptide 
reactivity (compare peptides 114 and 115). The effect of individual asp 
residues was examined by comparing the reactivity of peptides with a single 
asp residue at the -1 position (peptide 111) or the -5 position (peptide 110) 
with the double ala peptide (peptide 115). The presence of an asp residue at 
the -1 position decreased the Km from 7.5 |iM to 1.4 pM compared with the 
double ala peptide whereas the presence of an asp at the -5 position 
decreased the Km to 2.1 ^iM. These results indicate that asp residues at the 
-1 and -5 positions enhance peptide reactivity in an additive fashion by 
decreasing the Km for the reaction. 
Acidic residues also enhance the reactivity of casein peptide 2 and 
angiotensin H with rrbPTP-l, To further investigate the importance of acidic 
residues N-termlnal to the phosphorylated tyrosine residue we determined 
the effects of deletions and amino acid substitutions on the kinetics for 
dephosphorylatlon of two other rrbPTP-1 peptide substrates. The presence 
of the asp residue at position -3 relative to phosphotyroslne in the 
angiotensin II peptide markedly decreased the Km for the reaction (16 fiM vs 
41-58 |iM) compared with peptides containing sar (N-methyl glycine) or no 
residue at this position (compare peptides AT-2 and AT-3 with peptide AT-1 
in Table 5). The magnitude of the effect was comparable to the effect of a 
single asp residue on the reactivity of the lysozyme peptide. The asp residue 
had no effect on Vm for the reactions. The presence of asn at the -3 position 
did not significantly Improve peptide reactivity (compare peptide AT-5 with 
peptides AT-2 and AT-3). Again the Vm values for the peptides were similar. 
The effect of glu residues on peptide reactivity was examined using a 10 
residue peptide based on the sequence surrounding the tyr-52 
phosphorylation site of as2-caseln. This peptide represented a C-terminal 
truncation of casein peptide 2 and the kinetics for dephosphorylatlon of this 
peptide were similar to those obtained with casein peptide 2 (Table 2). The 
presence of three glu residues at positions -1 to -3 (peptide 121) decreased 
the Km for the reaction by more than an order of magnitude (0.2 vs. 2.8 |iM) 
compared with a peptide containing ala residues (peptide 120) at the three 
positions (Table 5). The Vm values for the two peptides were similar. These 
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Table 5. Dephosphorylation by rrbPTP-l of Peptides Related to 
Angiotensin II and the 1^-52 Phosphorylation Site of as2-
Casein^ 
Rel 
Peptide Sequence Km Vm 
HM % 
Casein-Related Peptides 
121 MANEEEYSIG 0.2 100 
120 NANAAAYSI6 2.8 127 
Angiotensin Il-Related Peptides 
AT-1 DRVYIHPP 16 100 
AT-2 SarRVYIHPF 58 107 
AT-3 RVYIHPP 41 108 
AT-4 DRVYVHPF 15 89 
AT-5 NRVYIHPP 43 101 
a: Vm values for casein-related peptides and angiotensin Il-related peptides 
are expressed relative to peptides 121 and AT-1, respectively. Other 
conditions are described in Materials and Methods. 
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results indicate that the asp residue in angiotensin II and one or more of the 
three glu residues in the casein peptide enhance peptide reactivity by 
decreasing Km in a fashion similar to that observed with the lysozyme 
peptide. 
Effect of acidic residues on peptide reactivity with FTPS. The results of 
these experiments are shown in Table 6. The presence of the two asp 
residues at positions -1 and -5 of the lysozyme peptide (peptide 67-2) 
decreased the Km for the reaction by almost an order of magnitude (11.4 |iM 
to 1.8 |iM) compared with lysozyme peptide 115 which contains ala residues 
at the -1 and -5 positions. The Vm's for the two peptides were similar. In 
contrast asn residues at the two positions (peptide 114) had only a small 
effect on peptide reactivity. The presence of a single asp residue at the -1 or 
-5 position significantly decreased the Km for the reactions from 11.4 to 
3.9-4.0 |iM (compare peptide 115 with peptides 110 and 111). The effect of 
substituting ala for acid residues in the sequence surrounding the tyr-52 
phosphorylation site of as2-casein were also examined. The three glu 
residues at the -1 to -3 position relative to phosphotyrosine decreased the 
Km by more than an order of magnitude from 24.7 |iM to 0.6 |iM and 
decreased the Vm by ~2 fold (compare casein peptides 120 and 121). Taken 
together these results indicate that, like rrbPTP-1, acidic residues on the N-
terminal side of phosphotyrosine increase peptide reactivity with PTP-5 in 
an additive fashion by decreasing the Km for the reaction. 
Effect of other polar residues on lysozyme peptide reactivity with rrbPTP-l 
and FrP-5. In addition to the two asp residues, there are four other polar 
residues N-terminal side of the phosphotyrosine residue in the lysozyme 
peptide sequence. The effects of these residues were examined by 
comparing the reactivity of the wild-type lysozyme peptide with that of 
peptides containing single or multiple ala for polar substitutions (Table 4). 
Single ala substitutions of the thr and ser residues at the -2 and -3 
positions (peptides 109 and 68-2, respectively) had no effect on the Km 
compared with the wild type lysozyme peptide (peptide 67-2). Additionally, 
substitution of the asp residue at -1 with ala produced an increase in Km 
that was not significantly different from the increase in Km observed when 
the three residues in the -1 to -3 positions were substituted with ala 
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Table 6. Effect of Ala Substitutions on the Dephosphoiylation by PTP-5 
of Peptides Related to Lysozyme and the 1^-52 Phosphorylation 
Site of as2-Caseln^ 
Peptide Sequence Ito Rel Vm 
|iM % 
Lysozyme-Related Peptides 
67-2 NTDGSTDYGILQI 1.8 ±0.1 100 
112 NTDGSTDYGILQI 2.6 ± 0.3 120 ± 30 
111 NTDGSTDYGILQI 4.0 ± 0.8C 101 ± 7 
110 NTDGSTDYGILQI 3.9 ± 1.5c 104 ± 42 
114 NTHGSTHYGILQI 8.7 ± 0.2b.d 111 ±10 
115 NTDGSTDYGILQI 11.4 ± 0.9b 106 ± 8 
Casein-Related Peptides 
121 NANEEEYSIG 0.6 100 
120 NANAAAYSIG 24.7 233 
a: Vm values for lysozyme-related peptides and casein-related peptides were 
normalized to peptides 67-2 and 121, respectively. Other conditions are 
described in the legend to Table 4. 
b: p<0.01 vs. control; Cp<o.05vs. peptide 115; dp<0.05 vs. peptide 115. 
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(compare peptides 76 and 110 with the wild-type peptide 67-2). This 
indicates that the asp residue is the only residue in this region that effects 
peptide reactivity. Conversely, substitution of the asp at the -5 position with 
ala produced an increase in Km (1.8 fold) that was significantly smaller than 
the increase in Km observed when the three residues at positions -5 to -7 
were substituted with ala (3.5 fold). This suggests that other residues in 
this region may contribute to peptide reactivity. The best candidate seems 
to be the asn at position -7 because of the slight ability of asn to substitute 
for asp residues at the -1 and -5 positions and because substitution of asn 
at -7 with ala produced a small increase in Km (1.6 fold) although this 
increase was not statistically significant. Substitution of the thr residue at 
position -6 had no significant effect on Km. We conclude that ser and thr 
residues have no effect on peptide reactivity with rrbPTP-1 at least within 
the context of the sequence surrounding the tyr-53 phosphorylation site of 
lysozyme. In contrast the asn residue at -7 relative to phosphotyrosine may 
slightly improve peptide reactivity with rrbPTP-1. It is of interest that 
substitution of this asn residue with ala also produced a small increase in 
the Km for PTP-5 (compare lysozyme peptides 67-2 and 112 in Table 6). 
Comparison with other studies of FTP substrate specificity. Previous 
studies have shown that all three PTP classes, transmembrane, cytoplasmic 
and dual specificity, can dephosphorylate relatively short (8-20 residue) 
peptide substrates ( Guan & Dixon, 1990; Dunphy & Kumagai, 1991; Cho, 
et al., 1992; Hashimoto, et al., 1992; Ramachandran, et al., 1992; Ruzzene, 
et al., 1993; Cho, et al., 1993). While the present work was in progress two 
other studies of the effect of acidic residues on peptide reactivity with PTP's 
were reported. In one study it was found that a glu residue at the -1 
position and an asp residue at the -3 position of a peptide based on the tyr-
416 phosphorylation site of src increased peptide reactivity with the T cell 
PTP ~2 fold compared with ala at the same position (Ruzzene, et al., 1993). 
The T cell PTP is another member of the intracellular class of PTP's. These 
results were based on initial rates measured at a single substrate 
concentration. Interestingly an asn at the -2 position of the peptide also 
improved peptide reactivity by ~2 fold. In a second study, the presence of 
an asp residue rather than an ala at the -1 position of a peptide based on 
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the tyr 771 phosphorylation site of PLCy increased peptide reactivity with 
the transmembrane FTP, HPTPP by decreasing the Km for the reaction (Cho, 
et al, 1993). In contrast substitution of an asp residue for gly at the -2 
position or substitution of asp for ala at the +2 position of this peptide had 
little or no effect on peptide reactivity. 
It has also been reported that basic residues decrease peptide reactivity 
with T cell PTP and HPTPp. A lys residue at the -2 position of a peptide 
based on the tyr-393 phosphorylation site of abl decreased peptide reactivity 
with the T cell PTP 4 fold compared with the corresponding peptide with ala 
at the -2 position (Ruzzene, et al., 1993). Similarly arg or lys residues at the 
+2 position of a peptide based on the tyr-771 phosphorylation site of PLCy 
decreased peptide reactivity by increasing the Km for the reaction 35 and 5 
fold, respectively compared to the corresponding peptide with ala at this 
position (Cho, et al., 1993). Basics do not inhibit at all positions since an 
arg residue at position -1 had no effect on the reactivity of the PLCy-related 
peptide with HPTPp. 
Comparison with protein tyrosine kinase substrate specificity. Acidic 
residues on the N-terminal side of tyrosine have also been implicated as 
positive determinants for substrate recognition by protein tyrosine kinases 
(Geahlen & Harrison, 1990). Substitution of glu residues at postions -1 or 
-4 in a peptide based on the tyr-416 autophosphoiylation site of ppGO^rc^ or 
asp residues at the -3 position of the pp60src_related peptide or angiotensin 
II increased the Km for phosphorylation by protein tyrosine kinases. 
Kinases influenced by acidic residues include EGF receptor, insulin 
receptor, p56^ck^ ppGO^'Src and Y73 P90 (the 90 kDa transforming protein 
of Y73 virus). The magnitude of the effect of single asp or glu substitutions 
on protein tyrosine kinase Km's (2-7 fold) is comparable to the magnitude of 
the effect of single asp substitutions on the Km's for PTP-5 and rrbPTP-1 (2-
3 fold). It is not known whether substitution of multiple asp and/or glu 
residues produces a synergistic effect on the reactivity of peptides with 
protein tyrosine kinases as observed with PTP's. 
A significant difference between PTP's and protein tyrosine kinases is 
that the Km values (0.3-40 mM) observed with peptide substrates for protein 
tyrosine kinases are much higher than the Km values (0.1-2.0 |iM) for the 
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best PTP-5, rrbPTF-l, T cell FTP and HPTPP substrates. Additionally in the 
one case where it has been tested, the Km for enolase as a protein tyrosine 
kinase substrate was 100 times lower than the corresponding peptide 
substrate. This suggests that secondary and tertiary structure may play an 
important role in substrate recognition by protein tyrosine kinases whereas 
primary structure seems to be critical for substrate recognition by rrbPTP-1 
and PTP-5. 
Summary. The present study is the first to quantitatively relate the 
reactivity of PTP's towards a protein and its cognate peptide substrate. It 
was found that short peptides (10-11 residues) possess all or nearly all of 
the structural features necessary for high reactivity with two intracellular 
PTP's, rrbPTP-1 and PTP-5. Investigation of structural features necessary 
for tliis high reactivity indicated that asp or glu residues within 4-5 residues 
on the N-terminal side of tyrosine increased peptide reactivity with both 
PTP's in an additive fashion whereas asn residues had little or no effect. The 
effects of the acidic residues, which were as large as 20 fold, may be 
physiologically significant because many PTP substrates have acidic groups 
in the vicinity of the tyrosine phosphorylation sites. These results suggest 
that tyrosine phosphorylated peptides may be useful reagents for studying 
PTP substrate specificity. 
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ABSTRACT 
It has previously been shown that two intracellular PTP's from 
mammalian sources (rat brain PTP-1 and bovine brain PTP-5) 
dephosphorylate peptide substrates with much higher reactivity than simple 
aromatic phosphate esters, suggesting that peptides contain structural 
elements that increase peptide reactivity with these PTP's [Hippen, K.L., 
Jakes, S,, Richards, J., Jena, B.P., Beck, B. L., Tabatabai, L. B., & 
Ingebritsen, T. S. (1993) Bîjochemistry (in press)]. One of these elements was 
shown to be aspartate residues at positions -1, -3, or -5 relative to the 
phosphotyrosine, and glutamate residues at -1, -2, and -3. The acidic 
nature of aspartate was found to be important, as substitution with 
asparagine only slightly increased peptide reactivity. In the current study, 
we have addressed the effects of N-terminal acidic residues on peptide 
reactivity of an intracellular PTP from bacteria (YOP-51) and two 
transmembrane PTP's (rat brain LAR and human CD45). YOP-51, a distant 
relative of PTP-1 isolated from a bacterial plasmid, also showed an increased 
peptide reactivity with peptides containing acidic residues at -1, -3 and -5. 
Furthermore, the magnitude of the increase was similar to that observed 
with PTP-1 and PTP-5. In contrast to the intracellular PTP's, the effects of 
N-terminal acidic residues on peptide reactivity with the transmembrane 
PTP's was position dependent. For example, an acidic residue at position -3 
was found to increase peptide reactivity with both LAR and CD45. On the 
other hand, an acidic residue at -5 was unable to increase peptide reactivity 
with either PTP, In addition, CD45 was found to be unique from LAR in that 
an aspartate residue at position -1 increased peptide reactivity with LAR, 
but was found to decrease peptide reactivity with CD45. Replacement of 
aspartate with asparagine indicated that the acidic nature of the aspartate 
was responsible for the effects observed with YOP-51, but not for the effects 
observed with CD45 and LAR. These studies indicate that there Eire 
significant differences between members of the intracellular and 
transmembrane classes of PTP's (as well as differences between members of 
the transmembrane class of PTP's) as reflected in the influence of N-terminal 
acidic residues on peptide reactivity. 
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INTRODUCTION 
Phosphoiylation of tyrosine residues of cellular proteins has been shown 
to be involved in many signal transduction cascades, including mitogenesis 
(Ullrich & Schlessinger, 1990), oncogenesis (Bishop, 1991), T- and B-cell 
activation (Pingel & Thomas, 1989; and Justement et al., 1991, 
respectively), cell cycle progression (Gould & Nurse, 1989), cell fate 
determination (Perkins et al., 1992), and insulin effects (Ullrich & 
Schlessinger, 1990). The enzymes responsible for the addition and removal 
of phosphate from tyrosine residues are protein tyrosine kinases (PTK's) and 
protein tyrosine phosphatases (PTP's), respectively. 
The group of enzymes that make up the PTP family are numerous and 
diverse. Over sixty PTP's have been identified by biochemical and 
recombinant DNA studies, and these PTP's can be subdivided into three 
classes (Pot & Dixon, 1992): those that contain transmembrane and 
extracellular sequences, those that are intracellular, and those that show a 
dual specificity (i.e. those capable of dephosphorylating serine, threonine, 
and tyrsoine). 
The presence of such diversity in the PTP family raises questions about 
the mechanism for substrate recognition by PTP's and whether the 
mechanism differs among the various enzymes. Previous studies (Hippen et 
al., 1993) have shown that two intracellular PTP's (PTP-1 and PTP-5) were 
able to dephosphorylate protein and peptide substrates much more 
efficiently than simple substrates like p-nitrophenyl phosphate and 
phosphotyrosine, indicating that these substrates contained structural 
elements recognized by these two PTP's. One of these structural elements 
was found to be acidic residues at positions -5, -3 and -1 N-terminal to the 
phosphotyrosine. 
To address whether other PTP catalytic domains recognize acidic residues 
on the N-terminal side of phosphotyrosine, we have tested the effect of N-
terminal acidic residues with another intracellular PTP (YOP-51) and two 
transmembrane PTP's (rLAR and CD45). YOP-51, a PTP cloned from the 
bacteria Yersinia enterocolitica, was chosen because it represents a PTP 
isolated from a prokaryotic source (Guan & Dixon, 1990). The YOP-51 
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protein is produced from a gene located on a virulence plasmid, and it has 
been shown that phosphatase activity of this protein is required for bacterial 
pathogenesis (Bliska et al., 1991). CD45 (a.k.a. Leukocyte C.ommon 
^tigen, or LCA), a transmembrane protein expressed only on the surface of 
cells with hematopoietic lineage, has been shown to be required for both T-
and B-cell receptor mediated signal transduction cascades. The third FTP 
used in this study is rat LAR (rLAR, or Leukocjrte common ^tigen-Related 
protein). LAR is a FTP that contains extracellular domains with homology to 
both cell-cell adhesion molecules (e.g. N-CAM and flbronectin type III) and 
Ig-like molecules, and has been postulated to be involved in negative growth 
regulation by cell-cell interaction (Fearon et al., 1990). These PTP's have 
been chosen because, in addition to having known or postulated in vivo 
functions, they are also among the best biochemically characterized PTP's. 
While the effect of N-terminal acidic residues on peptide reactivity with YOP-
51 was similar to the other intracellular PTP's, noticeable differences were 
found with CD45, and LAR. 
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MATERIALS AND METHODS 
Materials. Sources of reagents have been previously described (Hippen et 
al., 1993). 
Peptide synthesis. Lysozyme- and casein-related peptides were 
synthesized in the Iowa State University Protein Facility by solid phase 
methodology on an Applied Biosystems 430A peptide synthesizer using 
methodology previously described (Hippen et al., 1993). The peptides 
obtained in this way were 70-90% pure. 
Preparation of ^^P labeled substrates. Protein and peptide substrates 
were phosphorylated and purified as previously described (Ingebritsen, 
1991; Hippen et al., 1993). Stoichiometrics for peptide phosphorylations 
ranged from 0.05-0.85 mol/mol for the various peptides. Baseline 
separations of the phosphorylated and non-phosphorylated lysozyme- and 
casein-related peptides was achieved using a linear acetonitrile/0.1% (v/v) 
TFA gradient (0.2%/min) across the phospho- and non-phosphopeptide 
peaks. Using this approach it was not possible to completely separate the 
phospho- and nonphospho-forms of the angiotensin II based peptides, but 
an enrichment of the phospho-form was obtained. 
PTP assays. Buffer conditions for PTP assays with YOP-51 and LAR 
were: 50 mM Tris (pH 7.0 at 25^0), 0.05 mM EDTA, 0.1% 2-
mercaptoethanol, and 1 mg/ml bovine serum albumin. PTP assays with 
CD45 were conducted in 25 mM HEPES (pH 7.4 at 25^0), 0.05 mM EDTA, 
0.1% 2-mercaptoethanol, 1 mg/ml bovine serum albumin, and 0.1% triton 
X-100. Quantitation of 32pj produced during the incubation of PTP with 
protein and peptide substrates was done as previously described (Hippen et 
al., 1993). When pNPP was used as a substrate, the reaction was 
terminated by addition of 1 ml of 0.2 M NaOH and the appearance of the p-
nitrophenolate anion was monitored by absorbance at 410 nm (Ingebritsen, 
1991). One unit of phosphatase activity is defined as the amount of enzyme 
needed to convert one iimole of substrate to products per minute at 30 ^ C. 
Data analysis. Apparent Km and Vm values for YOP-51, CD45, and LAR 
were determined from initial rate experiments using the non-linear 
regression analysis (Cleland, 1967). The experiments presented in Table 2 
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represent the mean of three independent phosphopeptide preparations, and 
the uncertainty was estimated by the SEM of the parameter. Statistical 
comparisons were made using the Student t-test. 
FTP'S used. The wild type YOP-51 was expressed in and purified from E, 
coli as in (Zhang et al. 1992). The rLAR used in this study is a recombinant 
form that contains only the cytoplasmic portion of the molecule. It was 
expressed and purified from E. coli as in (Pot et al., 1991). CD45 was 
purified from Jurkat cells, details of the purification are to be published 
separately. 
Other Protein Preparations. BIRK, a soluble, catalytically active form of 
the B subunit of the insulin receptor tyrosine kinase was purified from Sf9 
cells through the Sepharose fast Q step as in (Herrera et al., 1988). 
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RESULTS 
YOP-51, rlAR, and CD45 dephosphorylate peptide substrates with higher 
efficiencies than the simple aromatic phosphate ester, p-nitrophenyl 
phosphate. To determine whether elements in the vicinity of the 
phosphotyrosine affect the reactivity of YOP-51, CD45, and LAR, we have 
compared the catalytic efficiencies of peptides based on the phosphorylation 
sites of casein and RCM-lysozyme with p-nitrophenyl phosphate (pNPP) 
(Table 1). The data for peptide and pNPP dephosphorylation by YOP-51 is 
based on Vm/Km values. The data for rLAR and CD45 dephosphorylation 
of pNPP are also Vm/Km, and v/s values are presented for the peptides. It 
should be noted that v/s is an estimate of Vm/Km when [s]«Km. The 
peptide substrate concentration used for these experiments (1 [iM) is at least 
100-fold below Km for rLAR and CD45 since rates of dephosphorylation 
increase linearly up to ICQ |iM. 
The catalytic efficiency of casein peptide dephosphorylation by YOP-51, 
rLAR, and CD45 was much higher than that of pNPP ( 4700, 120, and 120 
fold, respectively). Similarly, the catalytic efficiency of lysozyme peptide 
dephosphorylation was significantly higher than that of pNPP (170, 18, and 
29 fold, respectively). More detailed analysis of Km and Vm values with 
YOP-51 indicated that increased efficiency is predominantly due to a 40-600 
fold decrease in Km, with only a small increase in Vm (4-8 fold). We 
conclude that peptides based on casein and lysozyme tyrosine 
phosphorylation sites contain structural features that enhance substrate 
reactivity with YOP-51, rLAR, and CD45. 
The catalytic efficiency of the casein and lysozyme peptides have also 
been compared to intact casein and RCM-lysozyme. For rLAR and CD45, 
the catalytic efficiencies for peptide dephosphorylation were within 3 fold of 
the catalytic efficiencies of the intact proteins. With YOP-51, the casein 
peptide catalytic efficiency was 2.5 fold higher than intact casein, but the 
lysozyme peptide was about 100 fold lower than intact RCM-lysozyme. More 
detailed analysis with YOP-51 showed that the Km for lysozyme peptide 
dephosphoiylation was 1,000 fold greater than the protein. This effect was 
partially compensated for by a 10 fold increase in Vm. Kinetic analysis of 
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Table 1. Kinetic Constants for Dephosphorylation of Various Substrates 
With Differing Complexity by LAR, CD45, and YOP-51^ 
YOP-51 rLAR CD45 
Substrate Km Vm Vm/Km v/sb v/sb 
|iM U/mg U/mg/nM 1 1 U/mg/|iM 
Casein 0.39 13.0 33.0 0.101 7.79 
Casein Peptide (121) 3.59 287.0 80.0 0.153 3.51 
RCM-lysozyme 0.06 14.0 241.0 0.075 0.636 
Lysozyme Peptide (67-2) 57.4 164.0 2.9 0.024 0.848 
pNPP 2200 37.0 0.017 O.OOIC 0.029c 
^These data represent the results of a single experiment. 
by/s (initial velocity over substrate concentration) approximates Vm/Km 
when the substrate concentrations used are much lower than Km. For 
these experiments, a substrate concentration of 1 |j,M was used. 
CThese values are based on Km and Vm values for these enzymes. The 
actual Km's for rrbLAR and CD45 were 1,900 and 2,840 )iM, respectively 
and the Vm's were 2.5 and 81.1 U mg'l, respectively. 
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casein and the casein peptide with YOP-51 showed that the Km for casein 
peptide dephosphoiylation was also greater (10 fold). However, this effect 
was compensated for by a 20 fold increase in Vm, thus the Vm/Km ratio of 
the casein peptide is greater than intact casein. It can be concluded that 
the catalytic efficiencies of peptides generally mimic the catalytic efficiencies 
of proteins with rLAR, CD45, and YOP-51. Even though the catalytic 
efficiency of YOP-51 dephosphorylation of the lysozyme peptide was 100 fold 
lower than that of ROM-lysozyme, this peptide still has a catalytic efficiency 
200 fold higher than pNPP. 
Effect of ala for asp or asn substitutions on peptide reactivity with YOP-
51, rLAR and CD45. The importance of N-terminal acidic residues at -1 and 
-5 on peptide reactivity with YOP-51, rLAR, and CD45 was determined by 
individually substituting these acidics with ala residues (compare peptides 
110 and 111 with the control peptide 67-2) (Table 2). Substitution of ala for 
asp residues at either -1 or -5 decreased peptide reactivity with YOP-51 (3.4 
and 2.5-fold, respectively). In contrast, the asp residue at the -5 position 
had no effect on peptide reactivity with the two transmembrane PTP's, rLAR 
and CD45. The asp residue at the -1 position increased peptide reactivity 
with rLAR but surprisingly decreased peptide reactivity with CD45. 
To check for other elements that might affect peptide reactivity, blocks of 
polar residues from -7 to -5, and from -3 to -1 were substituted with non-
polar alanine residues. Substitution of the -7 to -5 residues (peptide 77) 
decreased YOP-51 peptide reactivity to a higher degree than substitution of 
the aspartate at -5 (peptide 111) alone (3.8-fold as compared to 2.5-fold), 
although the difference in reactivity between these peptides were not 
statistically significant One possible explanation for this difference may be 
the asparagine residue at -7. Substitution of this residue with ala also 
caused a decrease in peptide reactivity with YOP-51 (1.5-fold), although this 
effect was also not statistically significant (Table 2). Previous studies with 
PTP-1 and PTP-5 have also found that this asparagine residue in the 
lysozyme peptide increases peptide reactivity (1.6 and 1.4 fold, respectively) 
(Hippen et al., 1993). 
The triple ala substitutions also indicated that the aspartate residue at -1 
was the only element in the polar residues from -7 to -5 and -3 to -1 that 
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Table 2. Effect of Ala for Polar Substitutions on Lysozyme Peptide 
Reactivity with YOP-51,rrbLAR, and CD45^ 
Peptide 
YOP-51 rrbLAR CD45 
Sequence Rel vi/[s]b Rel vi/[s]b Rel vi/[s]b 
% % % 
67-2 NTDGSTDYGILQI 100 ± IOC 100 ± 2.6C 100 ± 0.2c 
77 AAAGSTDYGILOI 29.6 ±4.5d 112 ±13.1 89.1 ±4.9 
112 ATDGSTDYGILQI 65.5 ±3.0 101 ±5.8 97.8 ± 4.3 
111 NTAGSTDYGILQI 39.6 ± 100 ± 7.0 91.5 ±3.3 
1.6d.e 
76 NTDGAAAYGILOI 35.8 ±7.8d 67.2 ±8.3 160 ± 1.5g 
110 NTDGSTAYGILQI 24.6 ± 46.2 ±4. id 171 ±4.4g 
0.9d.e 
114 NTNGSTNYGILQI 13.3 ±l.lf 87.9 ± 1.7e 110 ±5.4 
115 NTAGSTAYGILQI 7.48 ±0.1 44.0 ±2.0 175 ± 0.8g 
^v/s values represent the means +/- SEM of 3 determinations made with 
separate phosphopeptide preparations. Statistical comparisons were 
made using the Student-t test. 
bv/s values are expressed relative to peptide 67-2. Peptide synthesis, 
peptide phosphorylation and phosphatase assay conditions are described 
in Materials and Methods. 
^absolute v/s values for YOP-51 dephosphorylation of peptide 67-2 is 3.18 
U/mg/|iM, LAR is 0.024 U/mg/|iM, and CD45 is 0.848 U/mg/^iM. 
dp < 0.05 vs peptide 67-2, ^p < 0.005 vs peptide 115, fp < 0.05 vs peptide 
115, ëp < 0.005 vs peptide 67-2 
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increased peptide reactivity with LAR and CD45. Peptide 77 had a rate of 
dephosphorylation that was not statistically different from the parent 
peptide for both LAR and CD45, indicating the polar residues at -7 to -5 had 
no effect on peptide reactivity. The polar residues from -3 to -1 were found 
to have an effect on LAR peptide reactivity that was not statistically different 
from that of aspartate at -1 (1.5-fold increase vs. 2.2-fold). In addition, the 
increase in peptide reactivity observed for CD45 with the triple alanine 
substitution from -1 to -3 (peptide 76) was not statistically different from the 
effect observed with the single alanine substitution at -1 (peptide 110), 1.6-
fold vs. 1.7-fold. This indicates that the aspartate at -1 is the only residue 
that affects peptide reactivity in this region for both LAR and CD45. 
EJfect of double aspartate substitutions with alanine or asparagine on 
peptide reactivity with YOP-51, rLAR and CD45. In order to determine the 
effect of multiple aspartates, the rate of dephosphorylation by YOP-51 was 
tested with a peptide in which the aspartate residues at -1 and -5 were 
substituted with alanines (peptide 115). The rate of dephosphorylation of 
this peptide was 13 fold lower than that of the parent lysozyme peptide, and 
3-5 fold lower than either of the single aspartate substitutions. In contrast 
to the double aspartate substituted peptides were found to have reactivities 
similar to the single aspartate substituted peptide (at position -1, peptide 
110) for both LAR and CD45. This result was expected since replacement of 
the aspartate at -5 alone had no effect on peptide reactivity with either LAR 
or CD45. 
The importance of the acidic nature of the aspartate was tested by 
substituting the aspartates at -1 and -5 relative to the phosphotyrosine with 
asparagine residues (peptide 114). For YOP-51, the rate of 
dephosphorylation of this peptide was seven fold lower than the parent 
peptide, but about two fold higher than the double alanine substitution. 
The difference in reactivity between the double asparagine substitution and 
the double alanine substitution was statistically significant, indicating that 
asparagine is weakly able to substitute for aspartate in increasing peptide 
reactivity. In contrast, replacement of the aspartates with asparagines 
produced a slight, but statistically significant, decrease in the rate of 
dephosphorylation by LAR (12 %), indicating that asparagine is almost fully 
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able to substitute for the aspartate at the -1 position in increasing peptide 
reactivity (Table 2). The reactivity of CD45 towards the double asparagine 
substituted peptide was not statistically different from that of the parent 
peptide that contained aspartate residues, indicating that asparagine is fully 
able to substitute for aspartate at the -1 position in inhibiting peptide 
reactivity (Table 2). 
Effect of acidic residues on the reactivity ofYOP-51, LAR, and CD45 using 
casein peptide and angiotensin 11 peptide as substrates. To examine whether 
aspartate residues N-terminal to the phosphotyrosine affect the rate of 
dephosphorylation of other peptide substrates, a group of peptides based on 
angiotensin II, which has an aspartate residue at position -3 relative to the 
phosphotyrosine, were tested (Table 3). Additionally, the effect of glutamate 
residues N-terminal to the phosphotyrosine were tested by using peptides 
based on the phosphorylation site of casein, which contains three glutamate 
residues at positions -1, -2, and -3 relative to the phosphotyrosine residue 
(Table 3). 
As was found for substitution of the aspartate residues in the lysozyme 
peptide, the rate of YOP-51 dephosphorylation of the angiotensin II 
derivative in which the aspartate is substituted with sarcosine (N-methyl 
glycine) was decreased 4.5 fold, compared to the parent angiotensin II 
peptide (Table 3), indicating that aspartate at -3 is also able to increase 
peptide reactivity v/ith YOP-51. The importance of the acidic nature of the 
aspartate was also tested using a set of angiotensin II derivatives ([Val^l Atll 
and [Asnl.Val^] Atll) that differed only in the presence of an aspartate or 
asparagine at position -3. As was observed with the lysozyme peptides, this 
substitution decreased the rate of dephosphorylation (2.6 fold), indicating 
that asparagine is only weakly able to substitute for aspartate in increasing 
peptide reactivity of angiotensin II derivatives as well. 
Using these same peptides, replacement of the asp with sar was found to 
decrease the peptide reactivity of LAR (2-fold), while replacement with 
asparagine caused only a slight decrease in peptide reactivity (Table 3). 
These results are similar to those found for dephosphorylation of the 
lysozyme-related peptides, and indicate that aspartate at -3 is also able to 
increase peptide reactivity vdth LAR, and further demonstrate that 
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Table 3. Effect of Ala for Polar Substitutions on Peptide Reactivity with 
YOP-51, rrbLAR, and CD45a 
Peptide Sequence 
YOP-51 rrbLAR CD45 
Rel vi/[s]b Rel vi/[s]t> Rel vi/[s]b 
% % % 
Casein peptides 
121 NANEEEYSIG lOOC lOOC lOOC 
120 NANAAAYSIG 4.9 17.6 52.3 
Angiotensin n derivatives 
Atll DRVYIHPF lOOd lOOd lOOd 
[Sari] Atll SarRVYIHPF 21.8 52.6 52.1 
[Val5] Atll DRVYVHPF lOOe lOOe lOOe 
[Asn 1 .Val5] Atll NRVYVHPF 38.4 81.9 92.9 
^These data represent the results of a single experiment. 
bv/s values for casein related peptides and angiotensin Il-related peptides 
are expressed relative to peptides 121, Atll, and [Val^] AT II. Other 
conditions are described in Materials and Methods. 
^absolute v/s values for YOP-51 dephosphorylation of peptide 121 is 64 
U-mg"l-|iM"l, for LAR it is 0.153 U"mg"l-}xM"l, and for CD45 it is 3.51 
U-mg-l'iiM-1. 
^absolute v/s values for YOP-51 dephosphorylation of Atll is 0.121 U-mg" 
1-^iM'l, for LAR it is 0.007 U-mg"l-|aM'l, and for CD45 it is 1.00 U-mg" 
l-liM-l. 
^absolute v/s values for YOP-51 dephosphoryaltion of [Val^] AT II is 0.191 
U-mg-l-|iM-l, for LAR it is 0.006 U-mg-l-|aM-l, and for CD45 it is 1.26 
U-mg"l-|iM"l. 
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asparagine is almost fully able to substitute for aspartate in producing this 
effect. In contrast to the results obtained with CD45 using the lysozyme-
related peptides, replacement of the aspartate at position -3 of angiotensin II 
decreased the rate of dephosphoiylation (2-fold, Table 3). Additionally, 
substitution of the aspartate with asparagine produced only a minor 
decrease in the rate of dephosphorylation of the angiotensin II related 
peptides (7%). These results, along with those obtained for 
dephosphorylation of the lysozyme-related peptide with the asparagine 
substitution, indicate that asparagine can mimic aspartate in increasing or 
decreasing peptide reactivity with rLAR or CD45. 
Substitution of the three glutamate residues at positions -1, -2, and -3 
with three alanine residues was found to decrease peptide reactivity with 
YOP-51, LAR, and CD45 (20-fold, 6-fold, and 2-fold, respectively), indicating 
that glutamate residues are also able to stimulate peptide reactivity (Table 
3). It should be noted that since aspartate residues at -1 and -3 have 
opposing effects with CD45, it is not known whether the net decrease in 
peptide reactivity observed with the alanine substituted casein peptide is 
due to a positive effect of each glutamate, or some combination of positive, 
negative, and neutral effects. 
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DISCUSSION 
This study has shown that an intracellular FTP, YOP-51, and two 
transmembrane PTP's, CD45, and rLAR, dephosphorylate casein, RCM-
lysozyme, and peptides based on these phosphoiylation sites much more 
efficiently than the simple aromatic phosphate ester, p-nitrophenyl 
phosphate. This indicates that elements of phosphopeptide structure in 
addition to the aromatic ring and phosphate group are able to influence the 
rate of substrate dephosphorylation by these PTP's. Similar results have 
been obtained with two other intracellular PTP's, PTP-1 and PTP-5. 
Effects of N-terminal acidic residues on FTP peptide reactivity. The effects 
of N-terminal acidic residues on the reactivity of PTP-1, PTP-5, YOP-51, LAR 
and CD45 with peptide substrates are summarized in Table 4. The 
comparisons are based on peptides with no acidic residues and represent 
Vm/Km values for PTP-1 and PTP-5, and v/s values for YOP-51, CD45, and 
LAR. Note that v/s approximates Vm/Km at the substrate concentrations 
used in this study. 
One striking feature of these results is the remarkable similarity of the 
effects of acidic residues on the three intracellular PTP's. This is especially 
notable since YOP-51 is an enzyme isolated from the bacteria Yersinia 
enterocolitica, and PTP-1 and PTP-5, enzymes isolated from mammalian 
brain. These enzymes were found to be similar in three important ways. 
First, the placement of the aspartate does not appear to be extremely critical 
for increasing peptide reactivity, since aspartate residues at -1, -3 and -5 
were all found to increase peptide reactivity, and the magnitude of the 
effects were also similar. Another similarity is the importance of the acidic 
nature of aspartate residues since asparagine residues only slightly 
increased peptide reactivity. The third similarity is that multiple aspartate 
residues have an additive effect for each enzyme. 
Aspartate residues were also able to increase the peptide reactivity of the 
transmembrane PTP's, but the effects on the two transmembrane PTP's were 
different from each other and from those observed with the intracellular 
PTP's. In particular the position requirements for stimulation of peptide 
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Table 4. Effect of Acidic Residues on the Efficiency of Peptide 
Dephosphoiylation by Intracellular and Transmembrane PTP's^ 
Peptide # Sequence 
Intracellular 
PTP-lb PTP-Sb YOP-5lt> 
Transmembrane 
CD45b LARb 
Rel. 
Vm/Km 
Rel. 
Vm/Km 
Rel. v/s Rel. v/s Rel. v/s 
Lvsozvme related neotides 
115 NTAGSTAYGILQI 1 1 1 1 1 
111 NTAGSTjDYGILQI 4.7 2.7 5.3 0.53 2.3 
110 NTDGSTAYGILQI 3.2 2.9 3.3 0.98 1.0 
67-2d NTDGSTDYGILQI 8.7 6.0 13.3 0.57 2.3 
114 NTNGSTNYGILQI 1.8 1.4 1.8 0.63 2.0 
Casein related oeptides 
120 NANAAAYSIG 1 1 1 1 1 
121 NANEEEYSIG 11.0 17.7 20.4 1.9 5.7 
Angiotensin II related peptides 
SarRVYIHPF 1 NDC 1 1 1 
DRVYIHPF 3.4 NDC 4.6 1.9 1.9 
^Data for PTP-1 and PTP-5 are reproduced from earlier studies (Hippen, et 
al., 1993). 
t>The values given are relative to the parent peptide, and were determined 
from Vm/Km values for PTP-1 and PTP-5, and v/s values for YOP-51, 
CD45, and LAR. Values given for the lysozyme peptides represent the 
relative mean of 3 determinations made with separate phosphopeptide 
preparations, and the casein and angiotensin II related peptides 
represent a single determination. The standard error observed with the 
lysozyme peptides was +/- 24% of the value given exept that PTP-5 
dephosphorylation of peptide 110 was +/- 56%. Statistical comparisons 
were made using the Student T-test. Each lysozyme peptide had a 
p<0.05 or lower when compared to peptide 115 (except peptide 111 with 
rLAR and CD45, which was not statistically different). 
CND = not determined. 
^This sequence represents the "wild type" sequence found in lysozyme. 
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reactivity by aspartate residues were more stringent for the two 
transmembrane PTP's since the reactivity of peptides with rLAR was 
stimulated by aspartate residues at the -1 and -3 positions but not the -5 
position whereas the reactivity with CD45 was only stimulated by the 
aspartate at the -3 position. Another interesting difference was the finding 
that an aspartate at the -1 position inhibited peptide reactivity with CD45. 
Finally asparagine residues were almost completely able to substitute for 
aspartate residues in the stimulation of peptide reactivity with LAR and 
CD45 suggesting that the acidic nature of aspartate is less important than 
that found with the three intracellular PTP's. 
Other studies conducted on the effects of acidic residues on peptide 
reactivity using members of the intracellular class (T-cell PTP) and 
transmembrane class (HPTPp) of PTP's, have found results similar to what 
has been reported here. In one study, peptides based on the tyr-416 
phosphorylation site of ppGO^rc containing a glutamate residue at position 
-1, and an aspartate residue at position -3 relative to the phosphotyrosine 
increased the peptide reactivity of the T-cell PTP ~2 fold compared to alanine 
at these same positions (Ruzzene et al., 1993). Aspartate at position -1 of a 
peptide based on the tyr-771 phosphorylation site of PLCy was also found to 
increase the peptide reactivity of HPTPp. In contrast to the other 
transmembrane PTP's LAR and CD45, HPTPP was found to have Km's of less 
than 10 |a,M for dephosphorylation of several peptides. Similar to rLAR, but 
distinct from CD45, aspartate at the -1 position of the PLCy peptide was 
found to increase peptide reactivity by decreasing the Km of the reaction 5-
fold. The position of the aspartate residue was also important for increasing 
peptide reactivity with HPTPp, since substitution of an asp residue at the -2 
position of a PLCy based peptide did not increase peptide reactivity. 
Comparison of PTP substrate specificity with that of SH2 domains. Similar 
to the protein tyrosine phosphatases, src homology 2 (SH2) domains can 
bind tyrosine phosphoiylated peptides with high affinity. Crystallization of 
the SH2 domain of pSô^^^ bound to a high-affinity phosphopeptide has 
shown that this SH2 domain contains a pocket that binds an isoleucine 
residue three positions C-terminal to the phosphotyrosine (Eck et al., 1993). 
Another study has screened 14 different SH2 domains for selectivity in 
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binding phosphorylated peptides using a library that contains randomly 
incorporated amino acids at positions +1, +2, and +3 C-terminal to the 
phosphotyrosine (Songyang et al., 1993). Similar to what has been found 
for FTP'S in this study, phosphopeptides with acidic residues were found to 
preferentially bind to SH2 domains of the src family of kinases. However, 
the effect on FTP reactivity was from N-terminal acidics, whereas binding to 
the SH2 domains was due to C-terminal acidics. Molecular modeling of the 
ppBQsrc SH2 domain indicated that glutamate at position +1 would be close 
enough to form hydrogen bonds with lys^OO and/or tyr^02 (Songyang et al., 
1993). In addition to recognition of acidic residues, each SH2 domain tested 
showed selectivity for one of the hydrophobic amino acids: leucine, 
isoleucine, valine, methionine, or proline at position +3 C-terminal to the 
phosphotyrosine. 
This study, along with the previous work with PTP-1, PTP-5, the T cell 
FTP, and HFTPp are the first attempts at defining elements of substrate 
recognition for different members of the FTP family, as well as differences in 
substrate recognition between different FTP's. Indeed, these studies have 
found that acidic residues near the phosphorylated tyrosine residue 
influence the reactivity of all protein tyrosine phosphatases tested. 
Furthermore, significant differences have been found between the effects of 
acidic residues on the reactivity of peptide substrates with the intracellular 
FTP'S as a class and the reactivities of these substrates with transmembrane 
PTP's. 
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ABSTRACT 
This study has addressed the substrate specificity of five PTP's (PTP-1, 
PTP-5, YOP-51, CD45, and LAR) using peptides corresponding to tyrosine 
phosphorylation sites of proteins that are known or believed to be 
physiologically relevant protein tyrosine kinase and PTP substrates. These 
peptides were used because they represent greatly divergent primary amino 
acid sequences and previous studies have shown that peptides can be 
excellent PTP substrates and contain all the elements needed for high 
affinity recognition of protein substrates. All of the phosphatases were 
found to dephosphoiylate each of the peptides tested, but with varying 
efficiencies. This indicates that these PTP's have some degree of selectivity, 
but a rather broad substrate specificity. YOP-51, an intracellular PTP, 
showed the greatest degree of selectivity (800-fold), while LAR showed the 
smallest (22-fold). Determination of the kinetic constants for peptide 
dephosphorylation by PTP-1 and PTP-5 showed that these PTP's had Km's in 
the low |iM range. In addition to the differences in the range of selectivity, 
these PTP's differed greatly in their most reactive and least reactive peptides. 
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INTRODUCTION 
Protein phosphorylation is a widely used mechanism of reversible post-
translational modification. In eukaryotes, most protein phosphorylation 
occurs on serine/threonine or tyrosine residues. Protein tyrosine 
phosphatases (PTP's) are enzymes that specifically remove phosphate from 
tyrosine residues of cellular proteins. PTP's have been found in eukaryotes 
from yeast to humans and in the vaccinia virus, as well as in bacteria from 
the genus Yersinia. This family of proteins is very diverse and contains both 
receptor-like and intracellular forms. Many intracellular PTP's contain 
additional domains that may be responsible for subcellular localization. For 
example, the T-Cell FTP (Cool et al., 1989) has a basic region with homology 
to nuclear localization signals; PTP-1 has a hydrophobic tail that allows it 
to associate with the endoplasmic reticulum (Frangioni et al., 1992); PTP-
MEG shows homology to protein 4.1 in a region thought to mediate 
inositolphospholipid-dependent association with glycophorin (Gu et al., 
1991): PTP-1 C and PTP-ID each contain two SH-2 (SRC Homology 2J 
domains, and have been shown to bind activated growth factor receptors 
and themselves become tyrosine phosphoiylated (Feng et al., 1993; Vogel et 
al., 1993). 
The presence of such diversity in the FTP family has raised the question 
of whether these enzymes have specific sets of substrates or whether they 
have a broad substrate selectivity. We have previously shown that five 
PTP's, representing both transmembrane-linked and intracellular classes, 
were able to dephosphorylate peptide substrates with reactivities much 
greater than the minimal PTP substrate, p-nitrophenyl phosphate, 
indicating that structural elements in the vicinity of the phosphotyrosine 
were able to influence substrate reactivity (Hippen et al., 1993a; Hippen et 
al., 1993b). In addition, acidic residues on the N-terminal side of the 
phosphorylated tyrosine residue were found to affect peptide reactivity by 
each PTP. The three intracellular PTP's were found to have veiy similar 
responses to N-terminal acidic residues. In contrast, the effect of N-terminal 
acidic residues on the peptide reactivity of the two transmembrane PTP's 
was quite distinct from that found with the intracellular PTP's and also 
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distinct from one another. Others have also found that intracellular PTP's 
(the T-cell PTP in this case) and transmembrane PTP's (HPTP-p) have 
increased reactivity towards peptides with N-terminal acidic residues 
(Ruzzene et al., 1993; Cho, et al., 1993, respectively). 
Since PTP's are able to recognize structural determinants on peptide 
substrates, we have used twelve peptides based on proteins with known 
sites of in vivo tyrosine phosphorylation to address three questions about 
the substrate specificities of three intracellular PTP's (PTP-1, PTP-5, and 
YOP-51) and two transmembrane PTP's (CD45 and LAR). First, do some or 
all of the tyrosine phosphoiylated peptides act as high efficiency substrates 
for the five PTP's? Second, to what extent do the five PTP's discriminate 
among these peptide substrates (i.e. do the PTP's have broad or narrow 
substrate specificities)? And third, to what extent do the substrate 
specificities of the five PTP's overlap. 
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MATERIALS AND METHODS 
Materials. Sources of reagents have been previously described (Hippen et 
al., 1993a). 
Peptide synthesis. Lysozyme- and casein-related peptides were 
synthesized in the Iowa State University Protein Facility by solid phase 
methodology on an Applied Biosystems 430A peptide synthesizer using 
methodology previously described (Hippen et al., 1993a). The peptides 
obtained in this way were 70-90% pure. Other peptides were synthesized by 
Boehringer Ingleheim Pharmaceuticals, Inc. 
Preparation of ^^P labeled substrates. Peptide substrates were 
phosphoiylated and purified as previously described (Hippen et al., 1993a). 
Stoichiometrics for peptide phosphorylations ranged from 0.05-0.85 
mol/mol for the various peptides. Peptides were purified from unreacted 
ATP and baseline separations of phospho- and unphosphoiylated peptides 
acheived using a linear acetonitrile/0.1% (v/v) TFA gradient (0.2%/min) 
across the two peptide peaks. 
PTP assays. Buffer conditions for FTP assays with PTP-1, PTP-5, YOP-51 
and LAR were: 50 mM Tris (pH 7.0 at 250C), 0.05 mM EDTA, 0.1% 2-
mercaptoethanol, and 1 mg/ml bovine serum albumin. PTP assays with 
CD45 were conducted in 25 mM HEPES (pH 7.4 at 25°C), 0.05 mM EDTA, 
0.1% 2-mercaptoethanol, 1 mg/ml bovine serum albumin, and 0.1% triton 
X-100 as a detergant. Quantitation of 32pj^ produced during the incubation 
of PTP with peptide substrates was performed as previously described 
(Hippen et al., 1993a). 
Apparent Km and Vm values for rrbPTP-1, PTP-5 with the various 
substrates were determined from initial rate experiments using the non­
linear regression analysis (Cleland, 1967). 
PTP's used in this study. The PTP-1 used in this study is a truncated, 
recombinant form of rat brain PTP-1 (rrbPTP-1) produced by replacing the 
lys-323 codon with a stop codon by site-directed mutagenesis. Expression 
and purification of rrbPTP-1 was accomplished by expression of rrbPTP-1 as 
a fusion protein with glutathione-S-transferase, and liberation of active 
phosphatase by thrombin essentially as in (Guan & Dixon 1991). Bovine 
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brain PTP-5 was partially purified through the phosphocellulose step as in 
(Jones et al., 1989) and is free of other bovine brain PTP's. The YOP-51 
used in this study is the wild type recombinant form expressed and purified 
from E. coli as in (Zhang et al. 1992). The LAR used in this study is also a 
recombinant form that contains only the cytoplasmic portion of the 
molecule. It was expressed and purified from E. coli as in (Pot et al., 1991). 
CD45 was chromatographically purified from Jurkat cells, details of the 
purification are to be published separately. 
Other Protein Preparations. Sources of proteins have been previously 
described (Hippen et al., 1993a). 
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RESULTS AND DISCUSSION 
PTP's used in this study: The PTP's chosen for this study represent 
members of the intracellular and transmembrane classes of PTP's. 
Additionally PTP-1, PTP-5, and LAR have been isolated from mammalian 
brain; while CD45 represents a PTP expressed only on cells of hematopoietic 
lineage, and YOP-51 is encoded by a gene found on a plasmid from the 
bacteria Yersinia enterocolitica. Table 1 shows the catalytic domain 
sequence homology of four of the five PTP's used, PTP-5 has been omitted 
because the primary sequence is not presently known. 
Substrates used in this study: The twelve peptides used in this study to 
address PTP substrate specificity correspond to sequences surrounding the 
tyrosine phosphorylation sites of proteins that are known or believed to be 
physiologically relevant protein tyrosine kinase and PTP substrates. 
Included are tyrosine phosphorylation sites from the src family of protein 
tyrosine kinases (pp56^ck and pp56fy^), receptor tyrosine kinases (EGF 
receptor and PDGF receptor), other receptor molecules (P and y subunits of 
the nicotinic acetylcholine receptor and the Ç subunit of the T-cell receptor), 
and downstream effector molecules (PLC-y and MAP kinase) (see Table 2). 
Do some or all of the "physiologically relevant" peptides act as high 
efficiency substrates for the five PTP's tested? It was previously shown that 
peptides based oh the tyrosine phosphorylation sites of the model protein 
substrates casein and RCM-lysozyme were high efficiency substrates for two 
intracellular PTP's, PTP-1 and PTP-5, with Km's below 2.0 |aM and Vm 
values of greater than 3,000 nmoles/min/mg. In scanning the in vivo based 
peptides, several were found to have Km's of less than 1.0 |iM and 2.0 |iM 
for PTP-1 and PTP-5, respectively, indicating that high efficiency was not 
just a phenomena found with model substrates (Table 3). The peptide based 
on the PDGF receptor showed the highest reactivity of the in vivo based 
peptides for both PTP-1 and PTP-5. In addition, all of the peptides tested 
were found to have Km's lower than 30 |xM. As was found previously for 
PTP-1 and PTP-5 dephosphorylation of substrates with varying complexity, 
the Vm values varied by less than four fold (Table 3). 
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Table 1 Sequence homology of PTP's used^^ 
PTP PTP-1 YOP-51 CD45b LARb 
PTP-1 - 20 36 36 
YOP-51 20 - 24 24 
CD45b 36 24 - 48 
LARb 36 24 48 -
a: The sequences used for this comparison are: Rat brain PTP-1 (Guan, et 
al., 1990), Yersinia psuedoixiberculosis YOP-51 (Guan & Dixon, 1990), 
human CD45 (Ralph, et al., 1987) and rat brain LAR (Pot, et al., 1991). 
b: Only the first PTP-like domain of CD45 and LAR have been used here 
because previous studies have indicated that only this domain is 
responsible for catalytic activity. 
Table 2. Known T^osine Phosphorylation Sites and Their Effects 
? 
Protein Sequence Phosphoiylated Function of phosphotyrosine 
residue 
Model substrates 
casein NANEEEYSIG 52 
lysozyme NTDGSTDYGILQI 53 
src farrulv kinases 
PSELCK RLIEDNEYTAREG 394 
PSGLCK FTATEGQYQPQP 505 
p59fyn RLIEDNEYTARQG 421 
FTATEPQYQPGENL 531 
Receptor tyrosine kinases 
EGFR STAENAEYLRVAP 1173 
PDGFR SKDESVDYVPMLD 751 
Other receptor subunits 
nAChR-B ISRANDEYFIRKP 355 
nAChR-5 VISKAQEYFNIKS 372 
TCR-C GKGHDGLYQFLST 121 
LSTATKDYDALHM 132 
Downstream effectors 
MAPK HTGFLTEYVATRW 185 
PLC-YL EGRNPGFYVEANP 783 
Correlates with kinase activation 
Correlates with kinase inactivation 
Correlates with kinase activation 
Correlates with kinase inactivation 
Activates kinase by decreasing the Km 
for substrates 
Specific binding site for PI-3-kinase 
Act synergistically to increase the rate of 
rapid desensitization 
Correlates with T-cell activation 
Along with phosphorylation of thr-183, 
activates S/T kinase activity 
Correlates witii phospholipase activation 
Abbreviations used are: EGFR, Epidermal Growth Factor Receptor; PDGFR, Platelet Derived Growth 
Factor Receptor; nAChR-^ and -5, mcotinlc Acetylcholine Receptor j3 and 5 subunits; TCR-Ç, T-Cell 
Receptor Ç subunit; MAPK, Microtubule ^ sociated Protein Kinase (or mitogen activated protein 
kinase); PLC-yl. Phospholipase C- yl isozyme. 
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Table 3. Kinetics for PTP-1 and PTP-5 Dephosphorylation of Peptides 
Based on In vivo Phosphorylation Sites 
PTP-1 PTP-5 
Peptide Km Rel. Vm^ Km Vm^ 
kiM % |lM % 
Cas (121) 0.20 100 0.64 100 
Lys (67-2) 0.56 81 1.60 52 
Ick (394) 0.71 65 2.41 102 
Ick (505) 0.84 69 1.23 43 
fyn (421) 1.32 72 3.11 70 
fyn (531) 0.84 70 1.00 47 
PDGFR (751) 0.28 72 1.61 98 
EGFR(1173) 1.53 81 6.97 57 
AChRp (355) 4.11 52 12.6 48 
AChRS (372) 11.7 93 9.4 73 
TCRÇ (121) 1.73 81 7.82 54 
TCRÇ (132) 20.4 131 27.9 92 
PLCY (783) 2.07 54 3.50 31 
MAPK (185) 4.26 85 12.2 85 
a: Relative Vm values are expressed relative to the casein peptide at 100%. 
The absolute Vm for PTP-1 is 21 pmole/min/mg and for PTP-5 is 6.3 
limole/min/mg. 
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In attempting to define the kinetics for peptide dephosphorylation with 
CD45 and LAR, substrate concentrations of greater than 100 |iM were not 
sufficient to achieve saturation, indicating that these peptides are not high 
efficiency substrates for CD45 and LAR, Because of technical difficulty in 
producing large amounts of kinase phosphorylated peptides, this 
investigation has focused on the rate of dephosphorylation at a single 
substrate concentration of 1 |iM. In addition, the Km for YOP-51 
dephosphorylation of the lysozyme peptide (67-2) was over 50 [iM, and the 
reactivity of many of the peptides tested were lower than this peptide. 
Therefor, the analysis of peptide reactivity of YOP-51 has also focused on the 
rate of dephosphorylation at a single substrate concentration of 1 |aM. 
Using these criteria, several of the in vivo based peptides were found to 
have reactivities with YOP-51 similar to that of the casein peptide, indicating 
that in vivo peptides can be high efficiency substrates for a third 
intracellular FTP (Table 4). In addition, like PTP-1 and PTP-5, the peptide 
based on the PDGF receptor was found to have the highest reactivity of the 
in vivo based peptides. 
In contrast to the intracellular PTP's, the transmembrane PTP's LAR and 
CD45 have a much lower reactivity with the peptides based on casein and 
lysozyme Therefor, it was not known whether these peptides are just not 
optimal substrates for these PTP's, or whether these enzymes are inherently 
less active. The screen of in vivo based peptides found several peptide 
substrates that fell into the range of the casein and lysozyme peptides, but 
none that were more reactive (Table 4). This provides additional evidence 
that LAR and CD45 are perhaps inherently less active than the intracellular 
PTP's. One possible explanation for the low reactivity with LAR and CD45 
is, since the native constructs of these PTP's also contain extracellular 
sequences, the FTP activity could be activated by ligand binding. However, 
studies with T-cells have shown that the extracellular portion of CD45 could 
be substituted with an unrelated extracellular domain without affecting 
CD45's role in receptor mediated activation (Volarevic et al., 1993; Hovis et 
al., 1993 respectively). Other factors could also regulate the FTP activity of 
CD45. For example, binding of the cytoskeletal proteins fodrin or spectrin 
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Table 4, Comparison of Peptide Reactivity for Five PTP's With Peptides 
Modeled After In vivo Phosphorylation Sites 
Peptide 
PTP-1 PTP-5 YOP-51 CD45 LAR 
Rel. Vm/Kma Rel. Vm/Kma Rel v/s^ Rel v/s^ Rel v/s^ 
Cas (121) lOOb lOOb lOOb lOOb lOOb 
Lys (67-2) 21 18 7 24 15 
Ick (394) 16 17 22 28 30 
Ick (505) 15 14 5 54 5 
fyn (421) 13 10 14 28 22 
fyn (531) 29 20 4 ND 8 
PDGFR (751) 46 25 58 12 15 
EGFR(1173) 10 3 8 10 5 
AChRp (355) 2 2 1 21 34 
AChRg (372) 1 3 0.2 14 10 
TCRC (121) 8 3 3 20 7 
TCRÇ (132) 1 2 2 3 7 
PLCY (783) 5 4 4 55 12 
MAPK (185) 4 3 5 75 22 
High/Low (all) 85 73 400 22 30 
High/Low 40 19 234 7 22 
(physiological) 
a: Relative Vm/Km and relative v/s values are expressed relative to the 
casein peptide at 100%. 
b: Absolute Vm/Km values for PTP-1 and PTP-5 with the casein peptide are 
103 and 9.4 |imole/min/mg/|iM, respectively. Absolute v/s values for 
YOP-51, CD45, and LAR dephosphorylation of the casein peptide are 64 
|imole/min/mg/|iM, 3.2 |Limole/min/mg/|j,M and 0.15 
|amole/min/mg/|iM, respectively. 
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have been shown to increase reactivity 8-fold (Lokeshwar & Bourguignon, 
1992). 
To what extent do the five PTP's disriminate among these peptide 
substrates? Each of the PTP's were found to dephosphorylate all 12 
physiologically relevant peptides, indicating that each has a broad substrate 
specificity. In addition, there was a substantial degree of overlap in the 
specificities of these enzymes. However, each PTP showed a range of 
reactivities between the best and worst peptide substrates, and the degree of 
selectivity varied from PTP to PTP. YOP-51 showed the greatest degree of 
peptide selectivity (400-fold) followed by the other intracellular PTP's, PTP-1 
and PTP-5 (85 and 73-fold, respectively). The transmembrane PTP's, CD45 
and LAR showed only a 20 and 30 fold range of selectivity, respectively. 
The broad and overlapping substrate specificity observed for the protein 
tyrosine phosphatases is remarkably similar to what has been found for 
three of the best biochemically characterized protein serine/threonine 
phosphatases (PP-1, PP-2A, and PP-2C). In the case of the protein 
serine/threonine phosphatases, analysis of over 20 phosphorylation sites on 
13 proteins revealed that these three enzymes show broad substrate 
specificity, but also some degree of selectivity (Ingebritsen & Cohen, 1983). 
In addition, each of these phosphatases could be distinguished by their high 
reactivity with certain substrates. 
To what extent do the substrate specificities of the five PTFs overlap? 
Remarkable similarities in substrate specificity were found for the three 
intacellular PTP's (PTP-1, PTP-5 and YOP-51). This was somewhat 
surprising since YOP-51 shows no striking homology with PTP-1 that is not 
conserved with CD45 and LAR. In contrast, the substrate specificity of 
CD45 and LAR are clearly distinct from that of the intracellular PTP's, and 
from one another. The intracellular PTP's (PTP-1, PTP-5, and YOP-51) were 
found to have the highest reactivity with peptides based on the 
phosphorylation sites of tyrosine kinases (PDGFR, Ick, and fyn). One slight 
difference that can be seen between PTP-1, PTP-5 and YOP-51 is that 
peptides based on the catalytic domain phosphorylation sites of Ick and fyn 
are more reactive with YOP-51 than peptides based on the C-terminal 
phosphorylation sites. However, none of the peptides based on other 
81 
receptor associated proteins or other signal transduction proteins were good 
substrates. In contrast to the intracellular PTP's, peptides based on the 
phosphorylation sites of PLC'y(783) and MAP kinase(i85) were two of the 
best substrates for CD45. In addition, peptides based on the 
phosphorylation sites of the acetylcholine receptor p subunit and the T-cell 
receptor Ç subunit were also good substrates. Peptides based on the 
catalytic domain and C-terminal phosphorylation sites of Ick and fyn were 
all good substrates for CD45, but a slight preferance was observed for the 
two C-terminal based peptides. Like CD45, peptides based on the 
acetylcholine receptor P subunit and MAP kinase were some of the best 
peptide substrates with LAR. However, in contrast to CD45, but similar to 
YOP-51, peptides based on the N-terminal phosphorylation sites of Ick and 
fyn were good LAR substrates, but peptides based on the C-terminal sites 
were not. 
One final observation that can be made is that, although there does not 
appear to be an absolute rule correlating the number of acidic residues with 
peptide reactivity, the intracellular PTP's were found to have generally higher 
reactivities with peptides that contained multiple acidic residues. In 
contrast to the intracellular PTP's, peptides with multiple acidic residues 
were not generally better substrates for those enzymes of the 
transmembrane class that were tested (i.e. CD45 and LAR). 
Summary: This study on PTP substrate specificity, along with other 
studies on the effects of N-terminal acidic residues has come to five major 
conclusions. First is that peptides contain structural elements that are able 
to affect reactivity with divergant intracellular PTP's and transmembrane 
PTP's. Second, each PTP was found to have a broad substrate specificity, 
but each showed a limited range of reactivity with the various peptides. In 
addition, the range of selectivity observed varied among the PTP's tested, 
with the intracellular PTP's showing a greater range of selectivity than the 
transmembrane PTP's. Fourth, the response to N-terminal acidic residues 
was similar for each intracellular PTP tested, and this effect was quite 
distinct from that of either CD45 or LAR, which were also distinct from one 
another. Finally, the current study with in vivo based peptides has also 
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found that the intracellular PTP's showed similar substrate specificities, and 
this specificity was distinct from either CD45 or LAR, which was once again 
distinct from one another. 
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ABSTRACT 
The arginine specific modifying reagent phenylglyoxal has been used to 
probe a protein tyrosine phosphatase (PTP-1) for the presence of an active 
site arginine residue. Incubation of PTP-1 with phenylglyoxal resulted in a 
loss of phosphatase activity, with a second-order rate constant (26.2 M" 
Imin'l), indicating that only one mole of phenylglyoxal is required to 
inactivate one mole of PTP-1. Consistant with the modified arginine residue 
being in the active site, the phenylglyoxal induced inactivation of PTP-1 was 
inhibited by either a phosphopeptide substrate or a thiophosphorylated 
peptide (a specific PTP inhibitor). 
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INTRODUCTION 
Protein tyrosine phosphatases are enzymes that remove phosphate from 
tyrosine residues of cellular proteins. Comparison of various cloned PTP's 
have shown that these enzymes share a 200 amino acid stretch of homology 
that represents the consensus catalytic domain. The highest degree of 
homology is found in an 11 amino acid stretch known as the HC box, whose 
consensus sequence is [I/V]HCXAFXXR[S/T]G, where X is a non-conserved 
residue (Pot & Dixon, 1992a). 
The current study has used the arginine specific modifying reagent 
phenylglyoxal to probe for an active site arginine residue in PTP-1. We have 
found that PTP-1 is inactivated by phenylglyoxal. Consistent with the 
modified arginine being in the active site, inactivation was inhibited by a 
phosphopeptide substrate. 
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MATERIALS AND METHODS 
Materials. Phenylglyoxal was purchased from Sigma and [7-1 ^ c] 
phenylglyoxal was from Amersham. Sources of other reagents have been 
previously described (Hippen et al., 1993a). 
Modification of rat brain PTP-1 by phenylglyoxal and substrate protection. 
Rat brain PTP-1 (13 nM) was incubated with varying concentrations of 
phenylglyoxal at 25^0 in 30 mM bicarbonate buffer (pH 7.5 at 250C), 0.1% 
2-mercaptoethanol, and 0.01% Brij-35. In the protection experiments, rat 
brain PTP-1 (1,4 |iM) was incubated with 5 mM phenylglyoxal, conditions 
used for these experiments were the same as previously described, except 
that either a phosphopeptide substrate (NTDGSTDpYGILQI; 30 |iM) based 
on the phosphorylation site of RCM-lysozyme or a thiophosphoiylated 
peptide inhibitor (NANEEEpYSIG; 100 |iM) based on the phosphorylation 
site of casein were included. 
FTP assays, substrates, and inhibitors. PTP assays were carried out 
using conditions previously described (Jones et al., 1989). RCM-lysozyme 
and lysozyme based peptide were phosphorylated on tyrosine using the B 
subunit of the insulin receptor tyrosine kinase and phosphorylated proteins 
and peptides processed to remove unreacted ATP as in (Hippen et al., 
1993a). The thiophosphorlated peptide inhibitor based on the casein 
phosphorylation site was made similar to the lysozyme peptide, except that 
ATPyS was used, and after HPLC separation, DTT was added before the 
samples were dried to prevent oxidation of the thiophosphoiylated tyrosine. 
FTP prep. The PTP-1 used in this study is a truncated, recombinant form 
of rat brain PTP-1 (rrbPTP-1) produced by replacing the lys-323 codon with 
a stop codon by site-directed mutagenesis. Expression and purification of 
rrbPTP-1 was accomplished by expression of rrbPTP-1 as a fusion protein 
vyith glutathione-S-transferase, and liberation of active phosphatase by 
thrombin essentially as in (Guan & Dixon 1991). 
Other Protein Preparations. BIRK, a soluble, catalytically active form of 
the B subunit of the insulin receptor tyrosine kinase was purified from Sf9 
cells through the Sepharose fast Q step as in (Herrera et al., 1988). 
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RESULTS 
Inactivation of rat brain PTP-1 with Phenylglyoxal: In order to address the 
possibility of an active site arginine residue in rat brain PTP-1, this PTP was 
incubated at 25°C with varying concentrations of phenylglyoxal. The 
phosphatase activity of PTP-1 was found to decrease in a time dependant 
manner and was completely abolished with a 10 minute incubation with 10 
mM phenylglyoxal, suggesting the possibility of an active site aiginine 
residue (data not shown). The inactivation of PTP-1 obeyed psuedo-first-
order kinetics (Figure lA). Replotting the data as observed rate constant 
(kobs) vs. concentration of phenylglyoxal yields a straight line (Figure IB), 
indicating that only one mole of phenylglyoxal is required to inactivate one 
mole of PTP-1. The observed rate constant, 26.2 M'^min'l, is similar to 
that obtained for the inactivation of other enzymes by phenylglyoxal 
(Burburaj et al., 1991; Dong et al., 1991). 
Phosphorylated peptide substrate and thiophosphosphorylated peptide 
inhibitors protect PTP-IJrom phenylglyoxal inactivation. While the kinetics of 
PTP-1 inactivation indicate that only one mole of phenylglyoxal is required to 
inactivate one mole of PTP-1, it does not address whether this arginine 
residue is in the active site. Therefor, we have tested the ability of a 
phosphopeptide substrate based on the phosphorylation site of RCM-
lysozyme to inhibit the inactivation of PTP-1 induced by phenylglyoxal. The 
Km for dephosphorylation of this peptide under the conditions used for 
phenylglyoxal modification is 1.5 |iM. At a concentration of 30 |xM, which 
corresponds to approximately 90% of Vm, this peptide was able to inhibit 
the inactivation 70% (Figure 2), while the non-phosphorylated peptide had 
no effect. Since this peptide is a substrate for PTP-1, the amount of 
consumption that occured during the reaction was monitored, and found to 
be less than 20 %, assuring that the substrate concentration in the 
inhibition assay was at least 24 |xM throughout the course of the assay. 
Thiophosphorylated peptides have been shown to inhibit PTP's (Cho et al., 
1993). We have also tested whether phenylglyoxal induced activation could 
be inhibited by a thiophosphorylated peptide based on the phosphorylation 
Figure lA. Kinetic analysis of PTP-1 inactivation by phenylglyoxal. 
Symbols for the various concentrations of phenylglyoxal are: 
7.5 mM, open circles; 5 mM, open squares; 3 mM, closed 
circles; 1 mM, closed squares 
Figure IB. Replot of observed rate of PTP-1 inactivation vs. 
phenylglyoxal concentration. The observed rate constants 
were determined from Figure lA, and plotted vs 
phenylglyoxal concentration. 
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Figure >2. Phenylglyoxal induced inactivation of PTP-1 (open circles) is 
inhibited by a phophorylated peptide substrate (open squares) 
but not by a non-phosphorylated peptide (closed circles). 
94 
site of casein. The IC50 for this inhibitory peptide under the conditions 
used for phenylglyoxal modification was 5 |iM, and a concentration of 
lOOjiM was found to almost completely inhibit the phenylglyoxal induced 
inactivation of PTP-1 (Figure 3). These results are consistant with the 
arginine residue (s) modified by phenylglyoxal being involved in substrate 
binding or catalysis. 
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Figure 3. Phenylglyoxal induced inactivation of PTP-1 (open squares) is 
inhibited by a thiophophorylated peptide inhibitor (closed 
circles). 
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DISCUSSION 
Despite the importance of PTP's in regulating cellular signal transduction 
pathways, little is known about the mechanism for substrate binding and 
phosphate ester hydrolysis. Site directed mutagenesis and chemical 
modification have identified a cysteine residue, located in the HC box, that is 
required for activity (Pot & Dixon, 1992b; Pot & Dixon, 1992a). Further 
biochemical analysis with LAR and 6D45 has~shown that this residue 
participates in phosphate ester hydrolysis by forming a phospho-enzyme 
intermediate (Pot et al., 1991; Cho et al., 1992). Previous research with E. 
coli alkaline phosphatase and human prostatic acid phosphatase indicate 
that the catalytic mechanism of these enzymes also procédés via a phospho-
enzyme intermediate, although the catalytic residues used are serine and 
histidine, respectively (Jones et al., 1978; Van Etton, 1982). 
The present study has used the arginine specific modifying reagent 
phenylglyoxal to identify an active site arginine residue in rat brain PTP-1. 
The determination that the modified arginine residue in PTP-1 is in the 
active site is based upon two findings. First, the enzyme is inactivated by 
phenylglyoxal. Second, this inactivation is inhibited by a small 
phosphopeptide substrate or a thiophosphopeptide PTP inhibitor. The 
recombinant form of rat brain PTP-1 we have used contains 20 arginine 
residues, only one of which needs to be modified by phenylglyoxal for 
enzyme inactivation. The specific arginine residue that is modified has not 
been identified. However, in a screen for potentially important residues in 
the HC box of LAR, one of the amino acids that was identified as essential 
for enzymatic activity is the arginine at residue 1528 (Streuli et al., 1990). 
Furthermore, this residue is absolutely conserved among all known PTP's. 
The exact role of the arginine residue in substrate binding or phosphate 
ester hydrolysis is unknown, but several possibilities exist. One possible 
role for this arginine could be binding the phosphate oxygens, analogous to 
the role of arg 166 in E. coli alkaline phosphatase (Kim & Wyckoff, 1991), 
and arg 175 and 148 in the SH2 domains of pp60V-src and p56^c^, 
respectively (Waksman et al., 1992; Eck et al., 1993). Another possible 
function for this arginine residue could be simultaneous recognition of the 
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phosphate group and the aromatic ring by the non-terminal and terminal 
nitrogen atoms, respectively, as has been found for arg 155 of the SH2 
domain of ppGO^'Src (Waksman et al., 1992). A third possible role for this 
arginine residue stems from previous studies work done by this lab. We 
have found that acidic residues N-terminal to the phosphoiylated tyrosine 
enhance the peptide reactivity of several PTP's, and the acidic nature was 
found to be critical for this increase (Hippen et al., 1993a: Hippen et al., 
1993b). Therefor, an active site arginine residue may form a salt bridge with 
the carboxylate group of aspartate and glutamate and help facilitate binding 
of substrate to the phosphatase. 
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GENERAL CONCLUSIONS 
The goals of this project were to: 1) Identify structural elements that 
contribute to substrate recognition using model FTP substrates, 2) Study 
FTP substrate specificity using peptides based on proteins with known in 
vivo sites of tyrosine phosphorylation, and 3) Identify active site PTP 
residues involved in substrate binding and/or catalysis. 
Idenification of structural elements that influence substrate reactivity 
with FTP'S 
We have found that the reactivities of three intracellular PTP's (PTP-1, 
PTP-5, and YOP-51) and two transmembrane PTP's (CD45 and LAR) were 
affected by the presence of acidic residues on the N-terminal side of 
phosphotyrosine. In addition, the effect on the three intracellular PTP's was 
similar, while the effect on CD45 and LAR were distinct from the 
intracellular PTP's and from each other. Another difference was that the 
acidic nature was found to be important in contributing to the effect 
observed with the intracellular PTP's, but not with the transmembrane 
PTP's. These results demonstrate that substrate recognition by five different 
protein tyrosine phosphatases is influenced by structural elements in the 
vicinity of the phosphotyrosine, and that acidic residues are one of these 
elements. Recently, work done on another intracellular PTP initially cloned 
from human T-cells, TC-PTP, has also found that N-terminal acidic residues 
enhance peptide reactivity of this enzyme (Ruzzene et al., 1993). 
Furthermor, additional studies with the transmembrane PTP HPTPP indicate 
that the peptide reactivity of this enzyme is also increased by acidic residues 
on the N-terminal side of phosphotyrosine (Cho et al., 1993). These studies 
found that, like the other two transmembrane PTP's studied, the position of 
the acidic residue was important for increased reactivity with FIPTPp. 
However, a significant difference between HPTPp and the other 
transmembrane PTP's is that the Km's for dephosphoiylation of several 
peptide substrates were in the low |iM range, a finding similar to that of the 
intracellular PTP's (Cho et al, 1993). Interestingly, HPTPP is also distinct 
100 
from CD45 and LAR in that this enzyme contains only one, rather than two, 
PTP-like domains. 
Another structural element that affects FTP peptide reactivity are basic 
residues. Using peptides based on the tyr 771 phosphorylation site of PLCy, 
arginine or lysine residues at position +2 relative to the phosphotyrosine 
were found to decrease the peptide reactivity of HPTPP 35-fold and 5-fold, 
respectively (Cho et al., 1993). Similarly, using a peptide based on the tyr 
393 phosphorylation site of the abl kinase, a lysine residue at position -2 
relative to the phosphotyrosine was found to decrease the peptide reactivity 
of the T-cell PTP 4-fold (Ruzzene et al., 1993). 
However, there appears to be more elements involved in peptide reactivity 
than just acidic and basic residues, since peptides containing no acidics or 
basics are still much better substrates than the minimal substrate p-
nitrophenyl phosphate. Polar, non-acidic residues like serine and threonine 
are not likely candidates, since replacement of these residues with alanine 
did not affect peptide reactivity of PTP-1, PTP-5, YOP-51, CD45, and LAR. 
Two additional possibilities are peptide backbone interactions and/or 
hydrophobic amino acids. Future experiments could be performed to 
address these possibilities. 
Like PTP's, SH2 domains (domains with homology to the second domain 
of ppGOC-src) have been shown to specifically bind phosphotyrosine residues 
in the context of proteins or peptides. Furthermore, binding of the SH2 
domains to proteins and peptides has been shown to be site specific 
(Escobedo et al., 1991). Many of the structural elements that contribute to 
phosphopeptide recognition by SH2 domains have been found. However, 
unlike the protein tyrosine phosphatases, these elements were found on the 
C-terminal side of the phosphotyrosine residue. Crystalization of the SH2 
domain of p56^ck bound to a high-affinity phosphopeptide demonstrated 
that this SH2 contains a pocket that binds an isoleucine residue three 
positions C-terminal to the phosphotyrosine (Eck et al., 1993). Another 
study has screened 14 different SH2 domains for selectivity in binding 
phosphoiylated peptides using a peptide library that contains randomly 
incorporated amino acids at positions +1, +2, and +3 C-terminal to the 
phosphotyrosine (Songyang et al., 1993). Similar to the PTP's, acidic 
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residues were found to increase binding for SH2 domains of the src family of 
kinases, although this effect was due to C-terminal, rather than N-terminal 
acidic residues. In addition to recognition of acidic residues, all 14 SH2 
domains tested showed selectivity for one of the hydrophobic amino acids: 
leucine, isoleucine, valine, methionine, or proline at position +3 C-terminal 
to the phosphotyrosine (Songyang et al., 1993). Another interesting 
similarity between SH2 domain and FTP recognition of phosphopeptide 
substrates was the magnitude of effect from individual amino acids. 
Specifically, almost all of the individual amino acids (both acidics and 
hydrophobics) that enhanced phosphopeptide binding to the SH2 domains 
tested, did so by a factor of 2-5 fold, which is similar in magnitude to the 
effects observed for acidic residue enhancement of FTP peptide reactivity 
(Songyang et al., 1993). Therefor, the maximum selectivity of SH2 domains 
appears to be acheived by the additive effects of the selectivity for certain 
amino acids at multiple positions. 
Identification of FTP reactivity with in vivo based peptides and analysis 
of FTP substrate selectivity 
These studies found that intracellular PTP's can also show high reactivity 
with peptides based on in vivo based peptides, and these PTP's show very 
similar patterns of substrate selectivity. In contrast, no high efficiency 
substrates were identified for CD45 and LAR, although several in vivo based 
peptides were as reactive as the model substrates casein and RCM-lysozyme 
or peptides based on their phosphorylation sites. In addition, the pattern of 
substrate selectivity of CD45 and LAR were distinctly different from the 
intracellular PTP's and from one another. Finally, all the PTP's were shown 
to have a broad substrate specificity, but a varying range in their reactivity 
with their respective best and worst peptide substrates. 
These findings are in agreement with other studies done with the T-cell 
PTP, CD45, LAR, and HPTPp using peptides based on in vivo tyrosine 
phosphorylation sites (Ramachandran et al., 1992; Cho et al., 1992; 
Ruzzene et al., 1993; Cho, et al., 1993). These experiments have found that 
recombinant forms of the catalytic domains of these enzymes all have broad 
substrate specificities, but some degree of selectivity. In addition, these 
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studies found that the reactivities of CD45 and LAR were lower than those 
reported for the intracellular PTP's, In contrast to CD45 and LAR, HPTP 
(another transmembrane FTP) was found to have Km's in the low |iM range. 
Although earlier studies found that acidic residues on the N-terminal 
side of the phosphotyrosine were able to influence the peptide reactivity of 
PTP-1, PTP-5, YOP-51, CD45 and LAR, there does not appear to be an 
absolute rule for the in vivo peptide substrates correlating acidic residues 
with peptide reactivity. However, it was noted that peptides with multiple 
acidic residues were generally better substrates for the intracellular PTP's, 
but not for the transmembrane PTP's. In addition, the substrate selectivity 
of these five PTP's could not be explained by a possible negative effect of 
basic amino acids on peptide reactivity (as was found for the T-cell PTP and 
HPTPP) or a combination of positive and negative effects due to these 
charged residues. These results, like those found with peptides based on 
casein and lysozyme, indicate that PTP substrate reactivity is determined by 
elements in the vicinity of the phosphotyrosine in addition to acidic and 
basic residues. 
The data that has been accumulated for protein tyrosine phosphatase 
substrate specificity is remarkably similar to what has been found for the 
four biochemically characterized protein serine/threonine phosphatases (PP-
1, PP-2A, PP-2B and PP-2C). In the case of the protein serine/threonine 
phosphatases , analysis of over 20 phosphorylation sites on 13 proteins 
revealed that three of these phosphatases (PP-1, PP-2A and PP-2C) show 
broad substrate specificity, but also some degree of selectivity (Ingebritsen & 
Cohen, 1983). In addition, each of these phosphatases could be 
distinguished by their high reactivity with certain substrates. It has 
recently been found that the substrate specificity of PP-1 and PP-2A can be 
controlled by association with other cellular proteins. In addition to 
affecting the substrate specificity, some of these cellular proteins have been 
shown to target protein phosphatases to specific subcellular localizations, 
further restricting their ability to interact with certain substrates. 
It has been found that the in vitro specific activity of several intracellular 
PTP's is 10-1000 times greater than those of the protein tyrosine kinases 
(Fischer et al., 1991). The high specific activity and broad substrate 
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specificity found for these PTP's suggest that their activity may need be 
regulated in order for signal transduction cascades Involving 
phosphorylation of tyrosine residues to proceed. Interestingly, the 
intracellular PTP's identified thus far all contain sequences in addition to 
the putative catalytic domain. In addition, several of these additional 
sequences have homology to other protein domains that are predicted to 
influence the subcellular localization. Some examples of the proposed 
functions include: nuclear localization, endoplasmic reticulum localization, 
association with tyrosine phosphoiylated proteins (via SH2 domain), and 
inositolphospholipid-dependent association with glycophorin, a membrane 
bound protein (via band 4.1 like domain). In addition to the possible 
subcellular localization of the intracellular PTP's, many transmembrane 
PTP's have been identified that would show plasmamembrane localization. 
Therefor many protein tyrosine phosphatases are likely to be similar to 
protein serine/threonine phosphatases, in that they have a restricted 
subcellular distribution. Another similarity between the sequences outside 
the PTP catalytic domain and the proteins associated with the protein 
ser/thr phosphatases is that the presence of these residues have been found 
decrease the peptide reactivity of the T-cell PTP (Ruzzene et al., 1993). This 
role for the sequences outside the catalytic domain may also be present in 
other PTP's, since many of the in vitro specific activity determinations that 
have been performed have used recombinant PTP's containing only the 
catalytic domain, or purified PTP's that have been truncated in the 
purification process. 
The question of whether some transmembrane PTP's are inherently less 
active or whether they are quite specific, but their optimal substrates have 
not been identified remains unanswered. One possible explaination for the 
lower activity of CD45 and LAR with these peptides is that protein structure 
in addition to that in the vicinity of the phosphotyrosine may influence 
reactivity. CD45 and LAR were able to dephosphoiylate peptides based on 
casein and lysozyme at rates similar to the intact proteins. Another possible 
mechanism of activating CD45 and LAR is by ligand induced activation of 
the phosphatase activity. Ligand induced activation of CD45 phosphatase 
activity is doubtful, however, since chimeric CD45 molecules in which the 
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transmembrane and extracellular domains of CD45 were replaced with 
either the myristoylation site of pp60C-src or the transmembrane and 
extracellular domain of an allele of a major histocompatibility class 1 were 
able to substitute for native CD45 in the activation of T cells (Volarevic et 
al., 1993; and Hovis et al., 1993 respectively). Other possible mechanisms 
have been identified for increasing the phosphatase activity of CD45. 
Specifically, the cytoskeletal proteins fodrin and spectrin were found to bind 
CD45 both in vivo and in vitro. Additionally, binding of fodrin or spectrin in 
vitro was found to increase the phosphatase activity of CD45 by 8 and 3-
fold, respectively (Lokeshwar & Bourguignon, 1992), 
Identification of an active site arginine residue in PTP-1 
The arginine specific modifying reagent phenylglyoxal has been used to 
identify an active site arginine in the protein tyrosine phosphatase PTP-1. 
In addition, the active site of LAR has been shown to contain a cysteine 
residue (Pot & Dixon, 1992b), and cysteine to serine or alanine mutations 
have shown that this cysteine is critical for the activity of several other PTP's 
(Strueli et al., 1989; Guan & Dixon, 1990; Guan et al., 1990, Pot et al., 
1991). Further analysis of the catalytic mechanism of LAR and CD45 
indicate that phosphate ester hydrolysis proceeds through a phospho-
en^rme intermediate, and the phospho-acceptor residue is a cysteine. 
Although there is no sequence homology observed between protein 
tyrosine phosphatases, E. coli alkaline phosphatase, and human prostatic 
acid phosphatase, two similarities exist in their method of phosphate ester 
catalysis. Alkaline phosphatases and acid phosphatases have also been 
shown to proceed via a phospho-enzyme intermediate, although the 
phosphate-acceptor residues are serine and histidine, respectively (Jones et 
al., 1978; Van Etton, 1982). The crystal structure of E. coli alkaline 
phosphatase has also determined the presence of an active site arginine 
residue, where it stabilizes the charged intermediates and transition states 
throughout the reaction mechanism (Kim & Wyckoff, 1991). Similarly, 
studies with the arginine modifying reagent phenylglyoxal have indicated the 
presence of an active site arginine residue in prostatic acid phosphatase 
(Van Etton et al., 1991). An arginine residue has also been found in the 
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phosphotyrosine binding site of SH2 domains. The crystal structure of the 
SH2 domain of ppGO^'^rc indicates that two arginines (arg 155 and arg 175) 
are involved in binding of the aromatic phosphate. Similar to the active site 
arginine residue in E. coli alkaline phosphatase, arg 175 of ppGO^-src co­
ordinates two of the phosphate oxygens (Waksman et al., 1992). In 
contrast, arg 155 is responsible for the simultaneous recognition of the 
phosphate group and the aromatic ring by the non-terminal and terminal 
nitrogen atoms, respectively (Waksman et al., 1992). 
The arginine residue(s) that have currently been identified in rat brain 
PTP-1 could function similar to the arginine residues discussed above. 
However, another possible function for this arginine residue stems from our 
finding that acidic residues in the vicinity of the phophotyrosine increase 
peptide reactivity. Therefor, this arginine may also be involved in substrate 
recognition by forming salt bridges with acidic amino acids on the peptide 
substrate. 
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